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ABSTRACT 
Observational epidemiologic studies are commonly encountered as a source of 
clinical evidence in equine veterinary medicine and offer many advantages over 
experimental studies. First, naturally-occurring cases of disease are studied in 
epidemiological investigations, with results directly applicable to similar cases 
encountered by veterinarians. Second, these studies are desirable from a welfare 
standpoint in that only natural disease is studied: disease need not be induced 
experimentally for epidemiological studies. Finally, for many equine diseases, improved 
methods of control and prevention of disease have a greater impact on the burden of 
disease than the treatment of individuals. Thus, understanding the epidemiology of a 
disease is essential for improving health. 
The first objective of this dissertation is to provide readers with an understanding 
of the design, strengths, and limitations of observational epidemiological studies so that 
readers may be able to effectively and appropriately critique and interpret the 
conclusions of these studies.  For illustrative purposes, examples will be drawn for two 
important equine diseases, viz., Rhodococcus equi pneumonia and laminitis. 
The following chapters will provide the methods and results of two observational 
studies including a cohort study of Rhodococcus equi pneumonia in foals on a single 
breeding farm in Texas and a case- control study of pasture- and endocrinopathy-
associated laminitis in horses. The final chapter will describe limitations and obstacles 
encountered in the design, conduct, and analysis of these two studies as well as the 
future direction of research into these clinically important diseases. 
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CHAPTER I  
THE IMPORTANCE OF EPIDEMIOLOGIC STUDIES IN EQUINE VETERINARY 
MEDICINE 
Introduction 
Equine practitioners depend upon peer-reviewed literature for continued 
development of their foundation of knowledge. When faced with new advances in 
diagnostic tests, procedures, or therapies, veterinarians must evaluate the findings and 
determine the value over their current standard of practice in order to optimize care for 
their patients.  
In the midst of the so-called information era, it is becoming exceedingly more 
difficult for the busy practitioner to keep abreast of current medical advances. 
Furthermore, with scientific literature widely available to horse-owners, practitioners are 
constantly faced with the need to interpret information that clients may discover from the 
Internet. Accurately interpreting, disseminating, and applying this information can be 
challenging, but this critical appraisal of the veterinary literature is an important aspect 
of a clinical veterinarian’s daily work.  
Analytical studies, including either experimental epidemiologic studies (i.e., 
randomized, controlled clinical trials) or observational epidemiologic studies (i.e., cross-
sectional studies, case-control studies, and cohort studies) are commonly encountered as 
a source of clinical evidence and offer many advantages over experimental studies. First, 
naturally-occurring cases of disease are studied in epidemiological investigations, with 
results directly applicable to similar cases encountered by veterinarians. Second, these 
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studies are desirable from a welfare standpoint in that only natural disease is studied: 
disease need not be induced experimentally for epidemiological studies. Finally, for 
many equine diseases, improved methods of control and prevention of disease have a 
greater impact on the burden of disease than the treatment of individuals. Thus, 
understanding the epidemiology of a disease is essential for improving health. 
Articles published in peer-reviewed journals and publications have undergone an 
extensive process of critical peer-review. Nevertheless, published studies (both 
experimental and epidemiologic) can include both identified and unrecognized biases, 
giving an opportunity for misinterpretation of findings by readers.  While experimental 
epidemiological studies help limit bias, these studies are expensive to complete and 
relatively uncommon in equine medicine.  Consequently, observational epidemiological 
studies which are more prone to bias constitute the most relevant and abundant source of 
evidence for equine veterinarians.  The objective of this report is to provide readers with 
an understanding of the design, strengths, and limitations of observational 
epidemiological studies so that readers may be able to effectively and appropriately 
critique and interpret the conclusions of these studies.  For illustrative purposes, 
examples will be drawn for 2 important equine diseases, viz., Rhodococcus equi 
pneumonia and laminitis. 
Rhodococcus equi (R. equi) pneumonia and laminitis both have a significant 
impact on the health and well-being of the horse. These diseases have been studied 
extensively in an effort to further our understanding of their pathophysiology.  Despite 
significant efforts, the causal mechanisms have not been fully elucidated and prevention 
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and control still remain problematic. Epidemiologic studies are well-suited for studying 
complex, multifactorial diseases and can help identify modifiable risk factors for disease. 
Thus, the burden of disease may be reduced by guiding control and prevention measures, 
even without fully understanding the causal pathways.  For example, the occurrence of 
R. equi on farms varies, with disease occurring endemically at some farms, but only 
sporadically, or not at all at other farms.1 At endemic farms, only some foals are affected 
and we have not been able to fully explain this distribution of disease in the population.  
An improved understanding of why a particular foal might be at risk of developing 
disease would reduce the burden of R. equi pneumonia at endemic farms.   
The pathophysiology of laminitis is also complex and multifactorial, involving 
inflammatory, metabolic, vascular, and traumatic pathways.2,3  Significant efforts have 
been made in the past decade to further our understanding of this intricate disease; 
however, much of the research has been limited to experimental induction of disease. 
While valuable, these models are likely to poorly replicate the mechanisms of naturally-
occurring disease. Patient-based research has become more prevalent in recent years; 
however, thorough knowledge and understanding of risk factors for development of 
laminitis are still lacking.  Results of observational studies could help identify strategies 
for prevention and control of this debilitating disease.  
Observational Study Designs and Bias 
In clinical epidemiology, the 2 principal components of an association study are 
the exposure and the outcome. The exposure can be any measured factor, such as a risk 
factor, prognostic factor, diagnostic test, or treatment.  Exposures can be inherent 
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(unalterable) factors like age, sex, breed, etc., or modifiable factors like diet, exercise 
level, vaccination status, etc. The outcome generally refers to the development of a 
particular disease or death.  Observational studies attempt to quantify a valid association 
(e.g. odds ratio or relative risk) between the exposure and the outcome.   
The main types of observational study designs include case-reports or case-series, cross-
sectional studies, case-control studies, and cohort studies. In an observational study, 
study groups are compared but no intervention is made and no variables are 
manipulated: the animals are studied in a natural environment and results are directly 
relevant to the natural disease process.  
Study types are not all equal and the study design employed to measure an 
association between an exposure and an outcome greatly impacts the quality of the 
evidence obtained. The proposed hierarchy of evidenced-based medicine indicates a 
rising scale of quality of evidence (Figure A-1.1).4 Each observational study design has 
strengths but also potential limitations and inherent biases that can be minimized through 
careful planning and actions by the investigator. Recognizing these strengths and 
limitations (biases) is essential for accurate interpretation of results. 
The general public typically considers bias in a research study to be a 
preconception of the researcher that might influence their interpretation of study results. 
This lay understanding of bias is different than the epidemiological definition of bias. In 
patient-based, observational epidemiological studies, the goal is to measure valid 
associations. Bias, or the lack of validity, specifically refers to an inequality between a 
study-derived value and the true value resulting from a systematic error (i.e., bias) 
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present in the design of the study (i.e., how the participants were selected, data were 
collected, results were analyzed, or results were interpreted). A bias can result in either 
over- or under-estimation of the true magnitude of an association, affecting the validity 
of the study results.  Because the true values of the parameters being estimated are 
unknown, it is imperative for investigators to minimize systematic error through careful 
planning of study design5 and for readers to be vigilant for possible biases in the design 
and conduct of studies as they interpret results.   
There are 3 main types of systematic errors (i.e., biases) that occur in 
epidemiologic studies: selection bias, information bias, and confounding. 5 Selection bias 
occurs as a result of factors affecting selection of study subjects, such that the study 
population is not a random selection from a reference population to which results will be 
applied. Sources of such bias may include differences in participation, response rate, or 
inconsistency in follow-up. Information bias is a result of inexact recording of data. For 
categorical data (i.e., breed, gender, body condition score) this is known as 
misclassification error. For continuous data (i.e., respiratory rate, body weight) this type 
of error is known as systematic measurement error.5 These errors may result from poor 
quality of collecting data, of measuring exposures or outcomes, or of conducting the 
study. One of the most impactful forms of bias encountered in epidemiologic studies is 
confounding. A confounder is a risk factor for an outcome which is associated with both 
the exposure and outcome of interest, but which is not part of the causal pathway. If the 
association between the confounding variable and the outcome are not considered in the 
design of the study, a biased estimation of the exposure-outcome relationship may result.  
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Unfortunately, not all confounders are recognized or accounted for in observational 
studies.    
Random error can occur as a result of imprecision of measuring or collecting 
data, but this type of error is distinct from systematic error (bias): it influences precision 
but not validity of observations.  Different study designs are prone to different sources of 
bias.  It is imprudent to assume that the investigators have identified and addressed all 
biases in their studies, such that readers must be able to recognize possible sources of 
bias in clinical research reports. Biases do not generally occur as a result of intention on 
the part of investigators to mislead readers, and even the most experienced investigators 
may fail to recognize a possible source of bias in the design or conduct of their work. 
Descriptive Study 
Descriptive studies are frequently encountered in the equine literature, including 
case-reports and case-series. These studies provide a summary of either 1 or several 
patients with an outcome of interest, with no comparison to a control group. They may 
highlight a new or rarely reported disease or condition and may guide generation of a 
hypotheses about risk factors or outcomes of a disease.  Rhodococcus equi is most 
commonly considered a cause of pneumonia in foals less than 6 months of age. There 
are, however, isolated case reports and case-series of infection in adult horses with 
variable clinical presentations.6-10 While these reports provide interesting descriptions of 
the clinical signs, immune status, necropsy findings, and management of adults horses 
with R. equi, conclusions about causal pathways cannot be made from findings of these 
reports. 
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Cross-Sectional Study 
Cross-sectional studies provide a ‘snapshot’ of all variables (exposures and 
outcomes) which are assessed concurrently. With this study design, investigators can 
describe the prevalence and fixed (i.e., gender, breed) relationships between exposure(s) 
and outcome(s) variables. These studies are ideal for identifying the frequency a disease 
in a population and generating hypothesis of potential risk factors for development of 
disease. These studies are inexpensive and easy to perform. They do not, however, 
provide temporal information about the relationship of the exposure and outcome 
(disease) either in individuals or populations.  
Early research of R. equi (then Corynebacterium equi) by R.C. Robinson11 
sought to determine whether soil was a potential source of infection to the foal. Soil 
sampled at a small number of endemic and non-endemic farms identified the organism 
only on those farms in which disease was present in the foals. This simple cross-
sectional study generated hypotheses regarding the potential sources of infection of 
foals, leading to more extensive ecologic studies of the organism.   
With a cross-sectional study design, however, causal relationships might not be 
determined between the exposure and outcome variables.  A 2006 cross-sectional study 
conducted in Australia to further evaluate the association of the ecology of virulent R. 
equi and the epidemiology of disease concluded that “the prevalence of R. equi 
pneumonia was associated with the airborne burden of virulent R. equi”.12  Inhalation of 
virulent organism had long been suspected as the main route of pulmonary infection in 
foals. To test this hypothesis, air and soil samples were obtained from 28 farms over a 2-
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year period. Pneumonia caused by R. equi was endemic at some farms and other farms 
had no history of disease prior to or during the study period. The study revealed that 
farms with endemic R. equi had a higher airborne concentration of the virulent organism. 
One might conclude that the higher airborne concentrations caused a higher prevalence 
of disease; however, the airborne concentrations might be an effect of prevalent disease 
rather than the cause of disease. Despite this limitation, the referent study described here 
was seminal in providing useful information and hypotheses to be tested regarding 
airborne and soil concentrations of virulent R. equi and disease at horse farms. 
Prevalence of disease can be determined from cross-sectional studies. Prevalence is the 
number of individuals in a population that have a particular attribute or disease at a given 
time. For decades, the combination of macrolides and rifampin has been considered the 
standard of care for R. equi pneumonia. In 2010, Giguѐre et al. investigated the 
prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in R. equi 
isolates.13 Bacterial isolates from clinical cases were obtained from diagnostic 
laboratories. The study revealed that the overall prevalence of antimicrobial-resistant 
isolates was 3.7%. This information emphasized the importance of antimicrobial 
resistance, potentially guiding veterinarians on a more judicious course of antimicrobial 
administration. It is plausible, however, that selection bias resulted in an over-estimation 
of the prevalence. A limitation to the design of this study was that sample collection 
varied among foals, with some samples obtained prior to initiation of treatment and other 
samples obtained after treatment was commenced. Thus, the emergence of resistance 
might have been a result of antimicrobial therapy.    
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Case-Control Study 
Case-control studies can provide important information regarding risk factors for 
development of disease. In these studies, investigators first identify animals that have the 
outcome of interest (cases) and patients without the outcome/disease (controls). The 
exposure to a potential risk factor is then compared between cases and controls. This 
design allows for collection and evaluation of multiple exposures. Since data are 
collected rapidly, these studies are often inexpensive and simple to execute and are ideal 
when studying diseases which occur infrequently. Disadvantages of this type of study 
include the fact that the investigator may only evaluate a single outcome, historic data 
collection may be inaccurate, prevalence of disease cannot be determined, selection of 
an appropriate control group is extremely challenging, and many sources of bias are 
possible.  
Because the host and the environment are thought to be important for the 
development of R. equi pneumonia in foals, several studies have investigated farm-and 
foal-level characteristics. 14-16 Information was collected over a 2-year period from 200 
foals born on 2 farms with endemic R. equi pneumonia.15 Foals were followed forward 
in time, and classified as either developing pneumonia (cases) or not (controls). 
Variables, such as foaling location, passive immune status, and comorbidities were 
compared between the case and control groups. No apparent foal-level risk factors for 
development of disease were appreciated. This, of course, does not preclude the 
possibility that foal-level risk factors for development of R. equi exist: influential factors 
might have been unmeasurable or unrecognized.  
 10 
 
Selection bias is common in case-control studies.  A recent case-control study of 
pasture-and endocrinopathic-associated laminitis (PEAL) in horses was conducted using 
data collected from cases and controls examined by members of the American 
Association of Equine Practitioners.   Participating veterinarians were asked to collect 
data from a first-time (incident) case of laminitis not caused by grain-overload, a septic 
process, or contralateral weight-bearing. For each identified case, a healthy horse with 
no history of laminitis (healthy control) and a horse with a lameness in only 1 forelimb 
not caused by laminitis (lameness control) were then selected as controls. Historical data 
including dietary management, stable management, and farrier care were collected from 
all horses. Participation in this study was voluntary, such that responding veterinarians 
(and the horses they contributed) were possibly different from non-responding 
veterinarians. Although it was possible to compare respondents to non-respondents for 
some variables (e.g., geographic location), many characteristics of non-respondents were 
unknown such that the impact of this selection bias could not be accurately estimated.   
Selection of appropriate controls in a case-control study is always challenging.17 
Controls should be representative of the relevant reference population for the 
exposure(s) of interest. In the aforementioned laminitis study, following identification of 
a laminitis case, a healthy control horse, intended to be the “next horse evaluated 
routinely by the veterinarian” was selected for inclusion. It is conceivable that, for 
convenience, many of these control horses might have been owned either by the 
veterinarian themselves or acquaintances of the veterinarians. Horses owned by 
veterinarians and their acquaintances are potentially managed differently than horses in 
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the general population. This raises the possibility of a selection bias because the study 
group differed from the source population, possibly biasing the association of the 
exposure with development of laminitis. 
Information bias is also common in case-control studies and may result from 
inaccurate or imprecise data reporting. The validity of the data obtained in the case-
control study of PEAL was dependent upon the accuracy of participating veterinarians.  
This accuracy pertains to not only the outcome of interest (i.e., diagnosis of laminitis) 
but also exposure data.  For example, a veterinarian might have fictitiously reported an 
estimated age for a horse for which the true age was unknown in an effort to expediently 
complete the survey.   
Cohort Study 
In a cohort study, the investigator observes a group of subjects, or a cohort, over 
a period of time. The study subjects are classified by exposure status at the onset of the 
study and the rate of disease occurrence in exposed and unexposed groups is compared. 
There are many distinct advantages of a cohort study. This study design is considered the 
best observational design for determining a causal relationship between exposure and 
outcome because the temporality of exposure and disease are well defined.  
Additionally, because study subjects are first categorized by exposure status and 
followed for disease development, the incidence, or risk, of disease may be calculated. 
These studies are expensive to perform and are not ideal for studying rare disease. 
As an example, Wylie et al.18, sought to estimate the frequency of veterinary-diagnosed 
active laminitis in Great Britain in 2009-2011. A prospective, cohort study was 
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conducted using a convenience sample of veterinarians in the country, and seeking 
information about the number and clinical signs of cases evaluated by each practitioner. 
Because of the cohort design, this study was able to provide both prevalence and 
incidence data for laminitis.  The prevalence of veterinary-diagnosed active laminitis in 
this study was 0.5% and the incidence was 0.5 cases per 100 horse-years at risk (95% 
confidence interval 0.4-0.6%). This frequency was lower than that reported in other 
studies19 for this geographic region.  This discrepancy might be a result of 
misclassification bias, as seen with client-reported versus veterinarian-reported studies. 
Veterinarian-reported studies might underestimate the true proportion of affected 
animals if not all cases are managed by veterinarians, whereas owner-/carer-reported 
cases might overestimate occurrence because of misclassification of horses with other 
conditions as being laminitic.  
Associations identified in epidemiologic studies are not always causal and errant 
causal associations can arise from the bias described by epidemiologists as confounding. 
An excellent example of confounding was present in a recent retrospective, cohort study 
of R. equi (Coleman et al., unpublished) in foals on a large breeding farm in Texas 
(Figure A-1.2). In this study, medical records from all foals born on the farm during a 3-
year period were reviewed. Several exposures such as month of birth, gestational age, 
and method of hyperimmune plasma (HIP) administration were compared between cases 
(foals developing R. equi pneumonia) and non-cases (foals not developing R. equi 
pneumonia). Foals receiving 2 liters of HIP within the first 24 hours after birth were less 
likely to develop R. equi pneumonia compared to foals receiving 1 liter within 24 hours 
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(Figure A-1.3). However, both the cumulative incidence of disease on the farm (Figure 
A-1.4) and the method of HIP administration varied by year (Figure A-1.5).  When the 
method of HIP administration was stratified by year, there was no effect of the volume 
of plasma transfused on the development of pneumonia (Figure A-1.6a and A-1.6b). In 
this example, study year was a confounder because it was a risk factor for development 
of R. equi pneumonia and it was associated with the method of HIP administration (but 
was not a result of the method of administration).  Thus, the apparent association of the 
volume transfused with cumulative incidence of disease was actually the result of 
differences in incidence of year and the fact that year was significantly associated with 
the volume transfused.  Confounding variables can be addressed in a number of ways 
including consideration of potential confounders in the design of the study as well as 
accounting for them in the analysis of the data (such as the stratification procedure used 
in our example).  
A final caution is warranted for practitioners utilizing epidemiologic data. There 
are often 3 populations of interest in epidemiologic studies: the target population, the 
source population, and the study population. The target population is the population to 
which results could possibly be extrapolated. The source population is the population 
from which the study subjects are selected. Finally, the study population consists of the 
individuals in the study, which is typically a sample of the source population. In the 
mentioned cohort study of R. equi pneumonia, data were collected from a single farm in 
Texas. The study population includes the foals that were used in the study and the source 
population would include foals born on the farm. Ideally, results of this study could be 
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extrapolated to foals born on breeding farms in the United States, the target population; 
however, the ability to extrapolate results of a study rely on validity of the study design 
and the extent to which the study population is reflective of the target (extrapolated) 
population (Figure A-1.7).  Unfortunately, even results of well-designed epidemiological 
studies can have limited applicability to broader populations. 
Conclusions 
As equine veterinarians, our best evidence for clinical practice comes from 
observational epidemiologic studies because these are most directly relevant to patients 
(similar to those studied).  The quality of the evidence for determining causal 
associations in observational studies is dependent upon design and conduct that produces 
precise and valid results.  While all studies are subject to inherent bias, it is crucial that 
investigators identify sources of potential bias, limit bias in the design of a study, and 
acknowledge these biases when reporting the results. Furthermore, equine veterinarians 
should be comfortable with the principles, strengths, and limitations of epidemiologic 
studies so that they can effectively and accurately interpret and apply the results.  
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CHAPTER II  
FOAL-LEVEL RISK FACTORS ASSOCIATED WITH DEVELOPMENT OF 
RHODOCOCCUS EQUI PNEUMONIA AT A QUARTER HORSE BREEDING 
FARM 
Introduction 
Rhodococcus equi, a soil-saprophytic, gram-positive, facultative-intracellular 
bacterium, replicates in and destroys macrophages. It primarily causes severe pneumonia 
in foals as a result of pyogranulomatous lesions in the lungs.1 Pneumonia in foals most 
commonly develops between 1 and 3 months of age and infection is widely considered 
to occur as a result of a naive or immature immune system early in life.20 Pulmonary 
disease is most common; however, extra-pulmonary infection and immune-mediated 
inflammatory disorders also occur.21 Disease caused by R. equi is recognized worldwide 
and the welfare and economic impacts are large. Where the infection is endemic, 
prevalence is high, treatment is prolonged and expensive, and case-fatality rates are 
high.22 
The occurrence of R. equi varies among farms, with disease occurring 
endemically at some farms, but only sporadically or not at all at other farms.1  Prior 
studies have demonstrated that farms with large acreage, a large population of mare and 
foals, a high density of foals, and a transient populations of mare-foal pairs were more 
likely to have foals affected with R. equi pneumonia.14,23,24  Odds of disease do not 
appear to be higher at farms with either management practices deemed poor for 
infection-control or lacking preventive health practices.  
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While all foals are likely exposed to R. equi and seroprevalence among foals is 
high, 24, 25 only some foals residing on endemic farms develop clinical signs of disease. 
Limited evidence is available regarding foal-level risk factors for development of R. equi 
pneumonia. Factors that have been considered include exposure of the foal to the 
pathogen, 12,26-31 differences in the innate and adaptive host-immune response,32-34 and 
genetic differences.35  An epidemiologic study of foal-related risk factors for 
development of R. equi pneumonia conducted at 2 breeding farms in Texas failed to 
identify foal-level risk factors.15  
Despite advances in our knowledge of R. equi pneumonia, the interaction 
between the host, pathogen, and environment are complex and further identification of 
risk factors for development of disease could improve our ability to control or prevent R. 
equi pneumonia in foals. Thus, the purpose of this study was to identify foal-level risk 
factors associated with the development of R. equi pneumonia among foals at a large 
breeding farm in Texas with a recurrent problem of R. equi pneumonia. 
Materials and Methods 
Criteria for Selection of Cases 
A retrospective cohort study was conducted using data from foals born at a large 
breeding farm in Texas from 2009 through 2011.  Foals were identified using foaling 
reports prepared by the farm during the study period.  All data extraction was performed 
by a single investigator (MCC). The study was not subject to institutional review, but 
consent from the farm veterinarian was given to retrospectively review the records. 
Identity of individual horses and foals remained confidential. For the purpose of this 
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study, a case of R. equi pneumonia was defined as a foal between 3 weeks and 6 months 
of age that met the following criteria: clinical signs of pneumonia (fever and either 
cough or respiratory distress), sonographic evidence of hypoechoic lesions of the 
peripheral lung consistent with pulmonary abscessation or consolidation, and clinical 
suspicion of R. equi pneumonia documented in the medical record by the attending farm 
veterinarian. All case and non-case foals born on this farm from 2009 through 2011 that 
resided on the farm and had complete medical records available for at least 6 months 
were included in the analysis (Figure A-2.1). All data were analyzed in aggregate. 
Information Obtained for Dams 
Information collected for the dam of each foal included name, age, duration of 
gestation (days, based on last known breeding date), and whether the foal was carried by 
a recipient mare.  
Information Obtained for Foals 
Information collected from each foal included sex, breed, date of birth, location 
of birth at the farm (i.e., stall or pasture), and intended use of foal (i.e., ranch-bred or 
race-bred). Management style differed between foals that were categorized as race- 
versus ranch-bred. Race-bred foals were bred for the intent of future racing or Western 
performance (i.e., reining, cutting, reining cowhorse, and barrel horses). These horses 
were typically stalled in an 84-stall, dirt-floored barn to foal and for the first 3 days after 
foaling. Ranch-bred foals were bred for the intent of low-level performance and ranch 
work. These horses predominantly lived at pasture with daily monitoring by farm 
personnel. Within 24 hours of foaling at pasture, the mare and foal were herded to the 
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clinic (up to a 1-mile distance) for evaluation by a farm veterinarian and medical 
management as indicated.  
The following medical data, when available, were collected: results of serum IgG 
concentration at 1 day of age, details of administration of R. equi hyperimmune plasma 
(HIP), and selected hematological findings at approximately 1 week of age. 
Hematological parameters recorded were total white blood cell concentration (WBC), 
absolute neutrophil concentration, absolute lymphocyte concentration, packed cell 
volume (PCV), and automated platelet concentration. Further information collected 
during the first 6 months of life included: whether the foal was administered 
antimicrobials; whether the foal had any infectious respiratory tract disorder other than 
R. equi pneumonia; and, whether the foal had any other medical history in the first 6 
months of life. Rhodococcus equi HIP was routinely administered to foals at the farm. 
Data collected regarding HIP administration included the source of the plasma, number 
of transfusions, age at which the plasma was administered, and total volume transfused 
to each foal.  
If the foal developed R. equi pneumonia, data including age of onset of clinical 
signs, sonographic findings, and cytologic/microbiologic culture results of tracheal 
bronchial aspiration were recorded. Furthermore, it was recorded whether the foal 
recovered, was euthanized, or died. 
Data Analysis 
The relationship between the dichotomous outcome of disease (i.e., case or non-
case) and independent variables was examined to estimate the strength and direction of 
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any association. Continuous data were assessed for normality, summarized as median 
and range values, and analyzed using Student’s t test or Wilcoxon rank sum test.  
Categorical data were summarized using contingency tables and were analyzed using the 
χ2 or, when expected values in any cell were <5, Fisher’s exact test. Categories for some 
independent variables were recoded into biologically plausible groupings (e.g., month-
of-birth recoded as early or late spring). Missing data were left as missing (i.e., not 
imputed). 
Odds ratios (OR) with 95% confidence intervals (CI), obtained by logistic 
regression, were calculated as a crude measure of association between risk factors and 
development of R. equi pneumonia. To adjust for the effects of year, all individual 
independent variables were examined in a multiple logistic regression model that 
included year and the variable of interest. Variables were considered to be confounded 
by year if the adjusted OR was different from the crude OR by at least 30%.5 
A multivariable logistic regression model was built using forward stepwise 
selection to assess the magnitude and direction of the association of multiple factors with 
R. equi pneumonia and to obtain estimates of ORs for single variables after adjusting for 
effects of other variables associated with the outcome. Highly correlated continuous 
variables were identified using Pearson’s correlation coefficient (i.e., Pearson’s 
correlation coefficient >0.80), and only 1 of the correlated variables was selected for 
inclusion in the model if it was biologically plausible that they measured similar 
exposures.21 Using the likelihood ratio χ2 test, variables with P < 0.15 were entered into 
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the model and values of P > 0.15 were used as a cutoff for removal.  All possible 
bivariate interactions were assessed.  
Logistic regression analyses were performed using commercially available 
software.a Confidence intervals for the OR were derived using the standard errors of the 
logistic regression coefficients of maximum likelihood estimators. Goodness-of-fit for 
models was assessed by use of the Hosmer and Lemeshow method.36 For all analyses, a 
value of P ≤ 0.05 was considered significant.  
Results 
A total of 1236 foals were born at the study farm between 2009 and 2011. Of 
those, 787 foals met the inclusion criteria and were included in the analysis. Data from 
449 foals were excluded including 302 in which the medical records could not be located 
in the electronic medical record system and 147 in which the duration on the farm was < 
6 months. All foals were either Quarter Horses or Quarter Horse crosses.  
Among included foals, 419 (53%) were colts and 368 (47%) were fillies. A total 
of 209 (27%) met our R. equi case definition, of which only 9 foals (4%) were 
euthanized or died of the disease. Age of onset of clinical signs ranged from 27 to 124 
days of age, with a median of 62 days.  
Foals were significantly more likely to develop R. equi pneumonia in 2010 
compared to either 2009 (P < 0.01) or 2011(P < 0.01). The cumulative incidences of R. 
equi pneumonia on the farm were 16% (40/245) in 2009, 46% (124/272) in 2010, and 
17% (45/270) in 2011 (Table A-2.1 and Figure A-2.2). Based on the similar cumulative 
incidences of disease during 2009 and 2011 compared to 2011, data from 2009 and 2011 
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were combined and compared to that of 2010.  For all variables, the association of the 
independent variables and outcome of disease was evaluated, with and without adjusting 
for the effect of year.  
The proportion of affected foals varied by birth month (Table A-2.2) and was 
lowest in January. There was no significant association of R. equi pneumonia when 
birth-month was considered as a dichotomous variable based on foaling early (January 
through March) versus later (April through June) during the foaling season. Adjusting 
for effect of year using multivariable logistic regression did not change this finding 
(Table A-2.3 and A-2.4). 
Dam-Level Factors 
None of variables evaluated for the dam were associated with the development of 
R. equi pneumonia including duration of gestation, age of the mare, or whether the mare 
was a surrogate or biological dam (Table A-2.3). Results of these variables remained the 
same after adjusting for effect of birth-year (Table A-2.4). 
Foal-Level Factors 
Because all foals born on the farm were of Quarter Horse breeding, it was not 
possible to determine whether breed was associated with development of R. equi 
pneumonia. Sex was not associated with the development of disease (Tables A-2.3 and 
A-2.4).  Foals at the farm were bred either for the intended use of racing or Western 
performance (i.e., race-bred; 50%; 392/787) or for low-level performance (i.e., ranch-
bred; 50%; 395/787).  Location of foaling differed depending on intended use. Per ranch 
protocol, the majority (99%; 387/392) of race-bred mares were brought into the barn 
 22 
 
prior to their expected due date and allowed to foal in a stall. The majority of ranch-bred 
mares remained in pastures to foal (98%; 389/395) (Table A-2.5). Intended use and 
foaling location were highly correlated (Pearsons correlation coefficient 0.97, P < 0.01) 
Neither intended use nor location of foaling was significantly associated with R. equi 
pneumonia (Table A-2. 3), even when accounting for year (Table A-2.4). 
           Most foals at the farm (61%; 484/787) were routinely tested for adequacy of 
passive transfer of immunoglobulins around 24 hours of life using a membrane 
filter ELISA kitb. The proportion of foals with an IgG concentration ≥ 800 mg/dL 
was not significantly different in cases and non-cases, even after controlling for 
year (Tables A-2.3 and A-2.4).  Results of complete blood count performed 
between 6 and 11 days of age were available for 89% (699/787) of foals at the 
farm. There was no apparent association between being a case and total WBC, 
absolute neutrophil concentration, absolute lymphocyte concentration, PCR, or 
automated platelet count, even after controlling for year.   
   
Causes of concurrent illness and disease other than R. equi pneumonia were 
identified in 20% (153/773) of foals during the 6-month period of follow-up (Table A-
2.6). Diagnoses included failure of transfer of passive immunity, perinatal asphyxia 
syndrome, gastrointestinal disease, musculoskeletal disease, trauma, and respiratory 
disease not caused by R. equi.  Foals with a history of any medical condition were less 
likely (OR = 0.4; 95% CI, 0.2 to 0.6) to develop R. equi pneumonia than were foals 
without such history.  Neither the magnitude nor the significance of this association was 
modified by adjusting for year of birth (Table A-2.4).  Respiratory infections (RTI) not 
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attributed to R. equi were identified among 3% (24/787) of foals for which follow-up 
information was available. Significantly (P = 0.009) more foals were diagnosed with a 
respiratory tract infection in 2010 (7%; 20/272) compared to 2009 (0.8%; 2/245) and 
2011 (2/270; 0.7%) (Table A-2.7). Again, foals with a history of other respiratory 
infection were significantly (P = 0.05) less likely to be diagnosed with R. equi 
pneumonia (OR 0.2; 95% CI, 0.1 to 1.0). This difference remained significant (P < 0.01) 
after adjusting for year of birth (OR 0.1; 95% CI, 0.2 to 0.5).  
An antimicrobial agent was administered to 53% (409/772) of foals during the 
first 6 months of life. Procaine penicillin G (900,000 U/foal IM) and gentamicin (300 
mg/foal IM) were routinely administered to foals once daily for the first 3 days of life 
(PG3). Of the 409 foals receiving any antimicrobial agent, 308 (75%) were administered 
only PG3, 53 (13%) received PG3 and another antimicrobial, and 48 (12%) were 
administered a different antimicrobials. When considering foals that received 
antimicrobials at any time during the first 6 months, there was no difference in 
development of R. equi pneumonia (OR 1.0; CI 0.8-1.4) and there was no effect of year. 
When considering only those foals receiving PG3, foals receiving PG3 were more likely 
to be affected (OR 1.6; 95% CI, 1.2-2.2), and this effect was similar when controlling for 
year (OR 1.5; CI 1.1-2.1). 
During the study period, HIP was administered IV at the farm using 1 of 3 
protocols: 1) 1 L transfused within the first 24 hours from birth; 2) 2 L transfused within 
the first 24 hours from birth; or, 3) 1 L within the first 24 hours from birth and 1 liter at 
approximately 21 days of age. For the purposes of our analysis, administration was 
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dichotomized based on the volume administered within 24 hours following birth (i.e., 1L 
vs 2 L).  In bivariable analysis, the odds of R. equi pneumonia were significantly 
decreased for foals receiving 2 L of plasma than for foals receiving 1 L (OR 0.4; CI 0.3-
0.5). The protocol for transfusion of HIP varied significantly at the farm by year. In 2009 
and 2011, a majority (73% [178/243] and 99% [250/251], respectively) of foals 
receiving plasma were administered 2 L within the first 24 hours after birth. However, in 
2010, foals were most commonly transfused with either 1 L within 24 hours from birth 
(46%; 126/271) or 1 L at 24 hours and 1 L at 3 weeks of age (48%; 130/271) (Table A-
2.8).When year of birth was included in the model, the volume of plasma transfused 
during the first 24 hours from birth was not significantly associated with development of 
R. equi pneumonia (OR 1.4; CI 0.8-2.8) (Table A-2.3 and A-2.4).  The variables of year 
and volume of plasma administered during the first 24 hours from birth were strongly 
co-associated (Pearson’s correlation coefficient = 0.8; P = <0.01).  
In multivariable logistic regression modeling, the variables of year of birth and 
having a comorbidity remained in the final model. Foals born in 2010 were more likely 
to develop pneumonia than foals born in 2009 and 2011 (OR 3.6; 95% CI 2.4-5.6) and 
foals with a comorbidity were significantly less likely to develop R. equi pneumonia 
than foals with no history of other disease (OR 0.4; 95% CI 0.2-0.6) (Table A-2.9). 
Discussion 
R. equi pneumonia in foals is important from the standpoint of both welfare and 
economics. Prevalence is high on endemic farms, duration of treatment is prolonged and 
thus expensive, case-fatality rates are high, and future performance can be affected.22 
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Improved understanding of the risk associated with development of disease in foals 
would improve our ability to prevent and control infection. Thus, the aim of the present 
study was to evaluate foal-level risk factors for development of R. equi pneumonia in 
foals on a single, large breeding farm in Texas.  
The cumulative incidence of R. equi pneumonia was significantly higher for 
2010 than for the other years (2009 and 2011). Significant effects of year on the 
cumulative incidence of R. equi pneumonia have been reported previously.15  The reason 
for this difference is unknown, although there are a number of possible explanations. 
First, as a large ranch, personnel and management practices can vary among year, 
resulting in differences in detection or reporting of clinical signs of disease in foals. 
Management practices, including method of HIP administration, varied by year, and 
might have contributed to the differences in cumulative incidences. Second, changes in 
environmental factors or in airborne concentrations of virulent R. equi in the 
environment might explain the difference in cumulative incidence among years. A 
higher incidence of disease has been reported in association with dry climate and pasture 
conditions.37 Airborne concentration of the virulent organism has been positively 
associated with disease. Factors associated with an increased airborne concentration 
include warmer ambient temperatures, 26 decreased soil moisture, decreased grass height, 
and timing within the foaling season.12 Moreover, higher concentrations of airborne R. 
equi in stalls during early life have been associated with increased odds of disease.30 ,38  
Unfortunately, neither climatological data nor airborne concentrations of virulent R. equi 
were collected for the retrospective study reported here. Last, in 2009 and 2010, foals on 
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the farm were not sonographically screened for R. equi pneumonia, foals born in 2011 
were sonographcially screened in conjunction with another study conducted at the farm 
and in which farm personnel remained blinded to the results of screening. This 
difference in management of foals might have accounted for differences in prevalence of 
disease by year. Irrespective of the cause for this difference in cumulative incidence 
among years, this difference made it important to account for birth-year when 
considering the association of other independent variables with the odds of R. equi 
pneumonia. An important implication of this finding is the potential for confounding by 
year on management practices. Had we not accounted for the effects of year, we would 
have concluded that administration of 2 liters of HIP was superior to administration of 1 
liter.  
Bivariable and multivariable analyses indicated that foals with a comorbidity 
were significantly less likely to develop R. equi compared to foals without a prior illness. 
Similarly, foals with a prior respiratory infection (not caused by R. equi) were 
marginally less likely to develop disease than foals with no history of respiratory 
disease.  These findings are consistent with a prior study evaluating foal-level risk 
factors of disease that indicated foals with a history of respiratory tract disease were less 
likely to develop R. equi pneumonia.15 It is plausible that foals with R. equi pneumonia 
also had other forms of respiratory infections that were unrecognized by the veterinarian, 
that foals with other forms of infection were misclassified as not also having R. equi 
pneumonia, or that foals with other forms of infection were misclassified as having R. 
equi pneumonia. The ability of innate immune cells to control primary infections is 
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widely recognized, 39 and it is biologically plausible that activation of the innate immune 
system as a result of infections besides R. equi might have contributed to reduced risk of 
disease. Interestingly, prior antimicrobial use was not associated with a decreased risk of 
developing R. equi pneumonia.  Further research is warranted to determine if this effect 
is clinically significant.  
Management practices of race- versus ranch-bred horses at the farm differed, 
with location of foaling the most obvious difference. Interestingly, the intended use of 
the horse, and thus the location of foaling, was not associated with R. equi pneumonia. 
This contradicts prior studies indicating that foals born and maintained on pasture are 
less likely to develop disease.23  
Results of this study did not identify any dam-related factors associated with the 
development of R. equi pneumonia, including duration of gestation, age of the mare, or 
whether the foal was carried by the biological dam. These findings are consistent with an 
epidemiologic study performed in 2003 investigating foal-level factors associated with 
the development or R. equi pneumonia at 2 breeding farms in Texas, in which no dam-
related factors were associated with the development of R. equi pneumonia in their 
foals.15   
Characteristics of foals, such as birth-month and location of foaling, also were 
not associated with the development of R. equi pneumonia. Another study from our 
laboratory at 2 other farms in Texas15 also failed to identify any foal-related factors 
associated with the development of R. equi pneumonia. Hematological results at 1 week 
of age did not differ between cases and non-cases. A previous study indicated that total 
 28 
 
WBC and segmental neutrophil concentrations in peripheral blood of 2- and 4-week-old 
foals were significantly lower in foals that subsequently developed R. equi pneumonia 
compared to foals that did not. Another study revealed that an elevated neutrophil count 
was a good screening test for detection of infected foals prior to the onset of clinical 
signs, with a sensitivity and specificity for detecting disease of 79% and 91%, 
respectively.40 Further evaluation of the value of hematological factors for predicting R. 
equi pneumonia is warranted.  
It has been long proposed that both the innate and adaptive host-immune 
responses play a role in the pathogenesis of R. equi pneumonia among foals.41 Plasma 
containing antibody against R. equi is routinely administered IV to foals to prevent 
pneumonia. This practice has been demonstrated to reduce the cumulative incidence of 
R. equi pneumonia in both experimental and observational studies; 42-46 however, not all 
studies have demonstrated significant reduction in the incidence of disease following 
transfusion of R. equi HIP. 45,47 The ideal age and minimum effective dose have not been 
determined, although administration prior to infection is thought to be important.48 At 
the farm enrolled here, foals were routinely administered HIP; however, the method 
varied by year. During 2009 and 2011 (i.e., the years in which R. equi was least 
prevalent), the most frequent method of administration was 2 L of HIP within the first 24 
hours after birth (73% in 2009, 99% in 2011). In 2010, however, only 1 L of HIP was 
typically administered soon after birth. Bivariable analysis revealed an apparent 
association of a decreased risk of pneumonia in foals receiving a higher volume of 
plasma early in life. This association, however, was confounded by the effect of year. 
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Thus, the apparent association of the volume transfused with cumulative incidence of 
disease was actually the result of differences in incidence of year and the fact that year 
was significantly associated with the volume transfused.  Conclusions about the efficacy 
of volume of HIP plasma administration cannot be drawn from this study, further studies 
of the effects of volume and age of administration of HIP are warranted.  
The case fatality rate of 4% observed for foals with R. equi pneumonia in this 
study was relatively low, with values in the literature ranging from 8-80%.15, 22, 23, 49-51   
The reasons for the lower rate at this farm during the years of the study are unknown; 
however, improved awareness and clinical expertise of farm veterinarians and personnel 
and early and appropriate treatment are likely involved.  
As with any retrospective study, there were many limitations to the study 
reported here. The most commonly accepted method of making a definitive antemortem 
diagnosis of R. equi pneumonia includes cytologic identification of gram-positive 
coccobacilli and isolation of R. equi by microbiologic culture of fluid obtained by 
tracheal aspiration. For the study reported here, foals with suggestive clinical signs, 
sonographic findings, and clinical impression of the farm veterinarian were considered 
to have R. equi pneumonia. This might have resulted in some degree of misclassification 
of affected and unaffected foals. During 2011, transendoscopic-tracheal aspirations were 
performed for all foals in which there was a clinical suspicion of  
R. equi pneumonia, and all foals were confirmed by cytologic and microbiologic culture 
results to have R. equi pneumonia. These data indicate that misclassification bias in the 
preceding years was unlikely.  
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Foals in the present study were included only if they resided on the farm for at 
least 6 months with complete medical records available. This might have introduced 
some selection bias (selective entry bias) such that the composition of the study groups 
differed from that of the source population, biasing the observed association.5  
Due to the retrospective nature of the present study, several potentially 
confounding variables could not be measured.  From the medical records, data such as 
weather conditions, airborne concentrations of R. equi, and travel of the foals off the 
farm were not considered. Another significant limitation of this study was that it was 
performed at a single breeding farm in Texas. Results of this study cannot be 
extrapolated to other regions of the country because of difference in factors such as the 
environment and climate. Despite these limitations, this study provides useful 
information regarding foal-level risk factors for development of R. equi pneumonia and 
suggests many questions for future investigation.   
In summary, the present study did not reveal any significant foal-related risk 
factors for development of R. equi pneumonia. The reason(s) for variation in clinical 
incidence among years at breeding farms is worthy of investigation. The finding that 
foals with a prior disease are less likely to develop R. equi pneumonia is biologically 
interesting and might lead to strategies for immunoprophylaxis. The results of analysis 
of the volume of plasma transfused, birth-year, and their associations with R. equi 
pneumonia also provide a useful clinical example of the spurious results that can occur 
as a result of confounding management practices. 
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aSAS, SAS Institute Inc, Cary, NC. 
bSNAP test, IDEXX Laboratories, Westbrook, Maine, USA 
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CHAPTER III  
CASE-CONTROL STUDY OF PASTURE-AND ENDOCRINOPATHIC-
ASSOCIATED LAMINITIS IN HORSES 
Introduction 
Laminitis is a debilitating disease of the equine foot resulting in severe pain, 
lameness, and loss of athletic performance. 52 With a poor prognosis, severe degree of 
pain, and frequency of recurrence, the impact of laminitis is high from both economic 
and welfare standpoints.  It is estimated that the incidence of laminitis in the horse 
ranges from 1.5%-34%,53 with an estimated lifetime risk of 15%.54  Not only does this 
disease affect horses and horse-owners, but veterinarians also strongly desire improved 
understanding of this disease: a survey of members of the American Association of 
Equine Practitioners (AAEP) conducted in 2009 identified laminitis as the highest 
priority for research funding and investigation.55 
The etiology of laminitis is multifactorial and complex, comprised of 
inflammatory, metabolic, vascular, and traumatic pathways and processes. 2,3  The term 
endocrinopathic laminitis has been recently used to describe laminitis in horses with 
insulin resistance, pars pituitary intermedia dysfunction (PPID), obesity, and/or 
glucocorticoid administration,56 and has been recognized as the most common cause of 
laminitis in private equine practice. 57, 58 In the National Animal Health Monitoring 
System equine study performed in 2000, horse owners in the United States reported that 
pasture-associated laminitis and laminitis of unknown etiology were the most common 
forms of laminitis.59  
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Significant efforts have been made in the past decade to further our 
understanding of this complex condition; however, much of the research has been 
limited to the study of the mechanistic pathways following experimental induction of 
disease. While valuable, these models do not fully replicate the interaction of the 
multiple factors that result in the development of naturally-occurring laminitis.  Thus, 
the conduct of observational studies upon naturally-occurring cases of laminitis is 
necessary for the improvement of our knowledge and understanding of disease 
predisposition and the design of future investigations into the prevention and control of 
this debilitating disease60 Furthermore, identification of modifiable risk factors for 
laminitis should improve our ability to reduce the burden of disease in the future. A 
recent systematic review by Wylie et al.  identified inconsistent and conflicting results 
regarding the risk of development of laminitis,61 further supporting the need for well-
designed, observational studies to improve the strength of evidence.  Thus, the objective 
of this study was to investigate risk factors for the development of incident cases of 
pasture- and endocrinopathic-associated laminitis (PEAL) in horses attended by 
veterinary practitioners in North America.  
Materials and Methods 
Participant Recruitment  
North American members of the American Association of Equine Practitioners 
(AAEP) were recruited through the AAEP Annual Convention in 2011 in San Antonio, 
TX and through the AAEP website to participate in the study. A listing of 7,100 member 
veterinarians residing in the United States and Canada was obtained from the AAEP.  
 34 
 
Through this list, members were contacted through electronic mail and postal services in 
order to solicit their participation in the study.  Initial contacts were asked to indicate 
their willingness to participate through the study website or by direct contact with the 
Study Coordinator (MCC).  Each respondent received a secure name and password 
allowing access to the study website.  This website contained all study instructions, 
documents and electronic data entry forms. Each respondent was also mailed 
instructions for participation and data collection, complete study definitions, study 
questionnaires, detailed photographic instructions for obtaining body measurements, 
body condition scoring, blood collection tubes, measuring tapes, and a prepaid return 
envelope. Data were collected from January, 2012 through December, 2015. The study 
was approved by the Institutional Animal Care and Use Committee and the Clinical 
Research Review Committee of the College of Veterinary Medicine & Biomedical 
Sciences at Texas A&M University. Client consent forms were obtained for all horses 
included in the study.  
Case Selection 
This was a matched, case-control study in which participating veterinarians were 
asked to identify a laminitic horse and 2 control horses, one healthy and one lame 
(Figure A-3.1). Cases were defined as incident cases of laminitis that started showing 
clinical signs no more than 4 weeks prior to examination. Horses defined as having 
laminitis had evidence of bilateral forelimb lameness of Obel grade ≥ 2, 62 and at least 2 
of the following findings: sensitivity to hoof testers that was greatest in the region of the 
toe at the time of initial examination, a characteristic foundered stance, radiographic 
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evidence of laminar thickening, or gross or microscopic evidence of laminitis. Horses 
were excluded from the study as cases of laminitis if they had any of the following 
findings: history of previous laminitis, laminitis associated with sepsis, laminitis 
associated with a non-weight bearing lameness, laminitis associated with excessive grain 
consumption, other concurrent disease conditions of the foot, history of navicular 
disease, were an equid other than a horse or pony, or had radiographic signs of chronic 
laminitis such as rotation or remodeling of the third phalanx. 
Control Selection 
  For each case, horses from 2 different control populations were selected; a 
healthy horse (healthy control) and a horse with a forelimb lameness (lameness control). 
The healthy control was defined as any healthy horse residing at a different location than 
that of the index case of laminitis, ideally the next horse examined by the veterinarian 
for a normal wellness examination (i.e., vaccination, Coggins testing, health certificate, 
or routine dental examination). A lameness control was defined as a horse lame in 1 
forelimb only. Lameness must have been present for no more than 4 weeks’ duration and 
must have been scored as ≥3 according to the AAEP 5-point scale.63 During selection of 
the control animals, those that had a history of laminitis or clinical or diagnostic findings 
indicating a previous diagnosis of laminitis (e.g., divergent hoof rings, dorsal hoof 
dishing, or pre-existing radiographic findings consistent with laminitis such as rotation 
of the 3rd phalanx) were excluded.  
 
 36 
 
A priori sample size estimations indicated that approximately 200 cases and 400 
controls were required, based on assumptions of a significance level of 5%, statistical 
power of 80%, an odds ratio of 2 for cases relative to controls, and 2 controls per case.  
Data Collection  
For each horse enrolled in the study, a questionnaire was completed by the 
owner/agent and veterinarian to capture the following data: 1) signalment (age, breed, 
and sex); 2) activity type and level; 3) housing and stable management; 4) pasture 
exposure and characteristics; 5) dietary and feeding practices; 6) body condition score 
and morphometric measurements 7) physiological factors (such as pregnancy and 
whether or not lactating);  8) history of PPID, equine metabolic syndrome (EMS), or 
obesity; 9) hoof care ; 10) recent transportation > 4 hours; and 10) history of 
corticosteroid administration. Data were entered via the study website by the 
veterinarian, or forms were returned by mail to the Study Coordinator for entry. All data 
were manually checked for apparent errors or discrepancies, which were then resolved 
through direct communications between the submitting veterinarian and the study 
coordinator. The questionnaire was pilot-tested prior to implementation. A gift 
certificate for $50 was provided to the veterinarian for submitting 1 or more case-control 
sets as an incentive for participation. 
Body Measurements 
  Using the Henneke scale64, height (at the withers), girth and waist (abdominal) 
circumferences, and neck circumference, a body condition score was determined for 
each animal. Girth circumference was measured caudal to the olecranon, behind the 
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withers. Maximal abdominal circumference (waist) was obtained by measuring body 
circumference two-thirds the distance from the point of the shoulder to the point of the 
tuber coxae. Neck measurements were obtained while the neck was in a neutral position, 
an angle of approximately. Circumference of the neck was obtained at the midpoint of 
the neck, described as the midpoint from the poll to the highest point of the withers. 
Photographs, illustrating the measurement procedures were provided to all participating 
veterinarians.  
Data Analysis 
  Descriptive data were generated for both cases and each population of controls. 
Univariable analysis of all variables was performed to evaluate the strength and direction 
of association with the development of laminitis. Categorical variables were tested using 
chi-squared or Fisher’s exact contingency tables, and continuous variables were 
compared using the Wilcoxon rank-sum test. Continuous variables were re-categorized 
into biologically plausible categories or quartiles. Contingency tables containing one or 
more “zero cells” were sensibly collapsed.36 Missing data were left as missing (i.e. not 
imputed). 
Data were analyzed separately for cases with each control group using 
conditional logistic regression (CLR) (1:1 match), with the analysis conditional on 
matched sets contributed by individual veterinarians. Bivariable models were fit, and all 
variables associated with laminitis at a value of P < 0.15 were included in a 
multivariable model using forward stepwise modeling. Variables selected into the final 
model were considered factors that best predicted the development of PEAL.  All 
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possible bivariable interactions among main effects variables significantly associated 
with laminitis were examined. Highly correlated variables (Pearson correlation 
coefficient >0.8) were identified and, if considered to measure similar exposures, 1 
variable was selected for inclusion based on biological plausibility and the magnitude of 
association. Variables were considered to be confounded if the adjusted odds ratio (OR) 
was different from the crude OR by at least 30%. 5 The associations of individual 
variables with laminitis were expressed as ORs, and 95% confidence intervals for the 
ORs were calculated using maximum likelihood methods. Commercially available 
software was used for all analyses (SASa). A value of P≤ 0.05 was considered 
significant. 
Results 
Veterinary Participation  
Of the 7,100 veterinarians initially contacted, a total of 625 veterinarians 
registered to participate in the study, 599 from the United States and 26 from Canada. 
Registered veterinarians represented all 50 states and 6 Canadian provinces. Among the 
registered veterinarians, 115/625 (18%) submitted data to the study, of which data from 
109 were eligible for analysis (Figure A-3.2). 
A total of 199 cases with at least 1 corresponding control were included in the 
analysis (199 cases, 198 healthy controls, and 153 lameness controls). Data were 
contributed from horses in 32 states and 3 Canadian provinces (Figure A-3.3).  
Submissions were received over a 4-year period including 174 (32%) received in 2012, 
177 (32%) in 2013, 91 (17%) in 2014, and 108 (20%) in 2015 (Figure A-3.4). Season of 
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onset of clinical signs was recorded for 196 of the laminitic horses, with 27 cases (14%) 
presenting in the winter, 66 cases (34%) presenting in the spring, 65 cases (33%) 
presenting in the summer, and 38 cases (19%) presenting in the fall (Figure A-3.4).  
Horses were significantly more likely to develop laminitis in the spring or summer as 
compared to the fall and winter months (P <0.0001).  
Horses  
Numbers and proportions of cases and controls (healthy and lameness) are 
presented in Table A-3.1. Results of bivariable conditional logistic regression for 
laminitic horses and healthy controls (Table A-3.2) and laminitic horses and lameness 
controls (Table A-3.3) were tabulated. Of the included horses, 251 (46%) were mares, 
281 (51%) were geldings and 18 (3%) were stallions.  Age was known and reported for 
547 horses, with a range from 1 to 34 years, a mean of 13.3 years, and a median of 13 
years. Neither sex nor age were risk factors for development of laminitis.  A wide variety 
of breeds were studied, including 237 (44%) Quarter Horses/Paints/Appaloosas, 70 
(13%) Thoroughbreds, 66 (12%) Drafts and European Warmblood, 48 (9%) Arabians, 
36 (7%) gaited horses (including Tennessee Walking Horses and Saddlebreds), 29 (5%) 
ponies and miniatures, and 17 (3%) Morgans.  Breed was not reported for 8 horses and 
was reported as ‘other’ for 28 horses.  
Obel grade was reported for all 199 laminitic horses. An Obel grade of 2 was 
reported for 119 (60%) horses, an Obel grade 3 was reported for 62 (31%) horses, and an 
Obel grade 4 was reported for 16 (8%) horses (Figure A-3.5). The etiology of the 
lameness was recorded for 84 of the 153 (55%) of the lameness controls (Figure A-3.6). 
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Final Multivariable Conditional Logistic Regression Models  
Final CLR models, conditional upon matched sets by submitted by individual 
veterinarian, were obtained comparing laminitis cases to healthy controls (Table A-3.4). 
Horses with an overweight body condition (≥ 7), generalized and/or regional adiposity, 
prior diagnosis of endocrinopathy, history of recent corticosteroid administration, and 
history of not being fed concentrate were at increased odds of developing laminitis.  
Results comparing laminitis cases to lameness controls yielded similar results as the 
healthy control comparison (Table A-3.5). Horses with an overweight body condition (≥ 
7), generalized and/or regional adiposity, and a diagnosis with a prior endocrinopathy 
were at increased odds of developing laminitis. There were no significant bivariable 
interactions between any pairs of variables in either model. 
Discussion 
This is the first reported observational study of veterinarian-diagnosed incident 
cases of PEAL in North America. The study identified several risk factors for 
development of disease that may guide future research into the pathogenesis, 
management, and prevention of this form of laminitis.  
Cases and corresponding controls were submitted by veterinarians over a 4-year-
period. A majority of cases were diagnosed during the spring and summer months. Data 
from prior studies regarding seasonality as a risk factor for development of laminitis are 
conflicting, 19, 65-66 which might be a result of differences in geographic location.   
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Signalment, including age, sex, and breed, have been evaluated as potential 
intrinsic risk factors for the development of laminitis in this and other studies.58,65,66,67 
Increasing age was not associated with increased odds of acute laminitis in the study 
reported here. Several previous reports have suggested a positive association between 
increasing age and risk of both acute and chronic laminitis, 58, 65, 67 while other reports 
have shown no association.66 Unlike the study reported here which was limited to first-
time cases of disease, the previous reports of risk of laminitis with increasing age might 
either indicate that increasing age is a risk factor for recurrent disease or merely an 
indicator of survival (i.e., prevalent disease). Indeed, our rationale for studying incident 
disease was so that factors associated with laminitis would be more likely to be risk 
factors for development of disease and not for survival or longevity. Previous studies of 
the association of sex and laminitis have yielded inconsistent results.61 No evidence of 
sex being associated with incident laminitis was observed in the study reported here. 
For the purpose of analysis, similar breeds (e.g., Paints and Quarter Horses) were 
combined to reduce the number of breed categories.  The odds of laminitis were 
significantly greater for Miniature Horses and ponies relative to Quarter Horses (P < 
0.002 for healthy controls, P < 0.010 for lameness controls).  Precision and power of this 
estimate was limited because the combination of Miniature Horses and ponies 
represented only 13% of laminitic cases and only 1% of both healthy and lameness 
controls. The odds of laminitis appeared lower for Thoroughbreds and 
Drafts/Warmbloods relative to Quarter Horses. Breed did not retain significance in either 
multivariable model. These findings are consistent with a recent systematic review of 
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risk factors for laminitis which revealed inconsistent results, with a majority of studies 
finding no breed association.61  
Undergoing a stabling change within 14 days of the onset of clinical signs was 
significantly associated with the development of laminitis in bivariable analysis for both 
populations of controls. The significance of this finding is unknown. It is possible that 
this was an effect of disease rather than the cause (i.e., horses with laminitis were more 
likely to be confined to a stall for purposes of disease management); however, this seems 
less plausible given that this observation was also true for the lameness control horses, 
and one might expect that these horses also would be more likely to have a stabling 
change to greater stall confinement for management of their lameness.  When further 
evaluated, neither an increase in exposure to grass nor a decreased exposure to grass was 
significant, indicating that the change itself but not a specific type of change was 
associated with increased odds of laminitis.  
It has long been proposed that access to lush grass is a risk factor for 
development of laminitis, although clinical evidence to support this is limited. In a 
survey performed by the USDA in 2000, owners reported that 46% of horses developed 
laminitis as a result of exposure to lush pastures.60 In another study, horses with new 
access to grass (with no access during the prior 4 weeks) were at an increased odds of 
laminitis compared to those with no access or with prolonged prior access.66 In the study 
reported here, horses exposed to lush, high-quality grass had an increased odds of 
developing laminitis compared to those either without grass exposure or with limited 
access to grass (when comparing cases to both populations of controls). However, this 
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variable was confounded by body condition score was not retained in either of the final 
multivariable models. 
Anecdotally, other dietary features, such as feeding high concentrate diets have 
been suggested to increase the risk of laminitis in horses. Interestingly, in the final model 
including healthy controls of the present study, horses receiving concentrates were at 
half the odds of developing laminitis than horses not fed concentrates, however, this 
variable was confounded by the effects of body condition score. The most biologically 
plausible explanation for this finding is that owners or carers had recognized horses as 
being “easy-keepers” and had eliminated unnecessary grain from the diet of these horses.  
This finding also suggests that interventions other than the amount of concentrates in the 
diet might need to be implemented to control body weight. Furthermore, specific 
information regarding the feeding practices of horses with PEAL should be evaluated to 
help guide further feeding recommendations. 
Body morphometrics have been evaluated in prior studies, with an increased risk 
of laminitis being associated with decreasing height,66 generalized obesity,67 cresty 
neck,67 and recent increase in body weight.66  In the current study, body morphometrics 
were extensively evaluated including subjective measures of BCS and the presence of 
generalized and/or regional adiposity (with descriptions of specific locations) and 
objective measurements including height, neck circumference, maximal abdominal 
circumference, girth circumference, and girth-height ratio. In the univariable analysis, all 
of these values were significantly associated with a risk of developing PEAL, including 
an obese body condition, the presence of generalized or regional adiposity, increasing 
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neck circumference, decreasing height, increasing maximum abdominal circumference, 
and increasing girth-height ratio. This finding was consistent in both control populations. 
Body condition score and the presence of generalized and/or regional adiposity were 
variables considered in the multivariable models, both of which were retained in the 
final models. The association of excess body weight and insulin resistance might 
contribute to the development of laminitis, although the pathophysiological mechanisms 
have not been fully elucidated. 69-70  Alternatively, increased body weight might 
contribute mechanically to the development of laminitis. The fact that we studied 
incident cases of laminitis strengthens the causal association of obesity and laminitis 
because the obesity preceded the onset of laminitis.  This strong association indicates 
that the risk of laminitis might be reduced by controlling obesity or modifying the 
underlying determinants of obesity. Careful feeding and management practices aimed at 
reducing body weight and adiposity should be considered. Although this concept is not 
new, 71 our evidence of the association of body morphometrics with the odds of  
developing laminitis should be compelling information for convincing veterinarians and 
horse owners of the risks associated with obesity and increased adiposity.  As noted 
previously, it is conceivable that strategies other than dietary management and exercise 
might be needed to prevent obesity. In human medicine, causes of obesity besides 
increased caloric intake and decreased expenditure have been identified, resulting in 
novel methods of obesity control and prevention. 72, 73 
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Both PPID and EMS have been previously associated with laminitis.74  In one 
study in a primary-care setting in the US8 and in another study in a tertiary care facility 
in Europe58, an underlying endocrinopathy was identified in a majority of cases 
presenting for laminitis. In the current study, the odds of laminitis were greater in horses 
with a prior history of PPID, IR, and/or EMS; however, the reported number of horses 
with any particular endocrinologic disorder was low. For this reason, we considered as a 
variable the presence of any endocrinopathy (rather than PPID, IR, or EMS 
independently) to gain statistical power for analysis. The low frequency of reported 
endocrinopathies in this population was surprising, but several plausible explanations 
exist.  The low numbers might be a result of reporting bias, in which veterinarians were 
uncertain of the medical history of the horse prior to evaluation for the current episode of 
laminitis, and thus were unaware of or did not report a prior endocrinopathy.  More 
importantly, it is possible that laminitis might be the first clinical sign of endocrinopathic 
disease recognized by horse owners or veterinarians. This is supported by the finding by 
Donaldson et al.57 that horses with laminitis can have PPID without other clinical signs 
of disease. These findings indicate that early recognition of endocrinopathic disease 
might lead to earlier therapeutic or management strategies that might reduce the 
likelihood of developing laminitis.   
Corticosteroid administration to horses has been implicated as inducing laminitis; 
75, 76 however, no direct evidence of a causal association has been identified. Although 
the use of corticosteroids in horses is widespread, the incidence of corticosteroid-
induced laminitis has been reportedly low both in observational studies investigating risk 
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factors for development of laminitis and in experimental studies of disease.60, 77-80 In the 
current study’s multivariable model comparing cases to healthy horses, the odds of 
laminitis were 13-fold greater among horses receiving corticosteroids relative to those 
that did not report having prior corticosteroids. The validity and magnitude of this 
association must be considered with caution.  Prior corticosteroid use did not remain in 
the final model with lameness controls, suggesting that the association seen with health 
controls might be confounded by another variable. More importantly, corticosteroid 
administration was uncommon in all groups of horses, with only 6% of cases, 2% of 
healthy controls, and 1% of lameness controls receiving steroids within 30 days prior to 
the onset of clinical signs. These small numbers rendered our estimates of effect size 
unstable (reflected in their wide 95% CI’s).  Recall of recent administration of 
corticosteroids is likely to be greater in laminitis cases than in controls, creating a 
potential for significant recall bias. Nevertheless, this topic merits further investigation 
using a well-designed, large-scale, hypothesis-driven observational study.   
The final multivariable models were similar for both sets of controls, with an 
obese body condition score, the presence of generalized and/or regional adiposity, and a 
previously diagnosed endocrinopathy identified as risk factors for development of 
laminitis in both models. Identifying these variables in comparison of cases to each 
population of control horses strengthens the evidence of the validity of the association.  
Studying incident cases of laminitis strengthens the likelihood of a causal relationship 
between these variables and laminitis.  To the extent that these risk factors (i.e., obesity, 
insulin dysregulation) are potentially alterable through diet, exercise, medication, or 
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other novel approaches, we consider the results of this study to be highly informative for 
laminitis prevention. 71  
In addition to the variables retained in the final multivariable model, other 
variables that were significantly associated with PEAL in bivariate analysis merit 
consideration. Significant association of these variables with covariates that were 
retained in the final model were observed, indicating that these variables might be 
important but not retained in the final model because they were co-associated with 
another variable.  For example, breed was significantly associated, though not 
confounded by BCS or the presence of generalized and/or regional fat.  Thus, breed 
might be a statistically important risk factor for laminitis, but adiposity or BCS were 
statistically superior and thus remained in the final model. 
As with any observational study, there are several limitations to this study. 
Participation was voluntary from veterinary members of the AAEP. The responding 
veterinarians likely differed from non-responding veterinarians, and the impact on 
selection bias cannot be definitively determined.  Furthermore, the validity of the data 
obtained was dependent upon the veterinarians. We relied on participating veterinarians 
to accurately report data, and it is our belief and hope that their responses were accurate.  
We did not, however, attempt to validate reported observations for either exposures (e.g., 
diet) or outcomes (e.g., laminitis). 
The response rate of veterinarians for participation in this study was low, which 
may have introduced selection bias. In a study performed by the AAEP in 2009, 71% of 
responding veterinarians expressed a willingness to participate in patient-based research 
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of laminitis. Nine percent of contacted veterinarians enrolled to participate, and of those, 
only 18% submitted data.  Lack of participation might have been attributed to the length 
of the questionnaire, the requirement of needing data from 3 horses, the busy schedules 
of practicing veterinarians, the need to identify incident cases of laminitis, and an 
inability to identify and collect data on the index case within 4 weeks of the onset of 
clinical signs. When the study was initially launched, the case definition required that 
data were collected within the first 48 hours following the onset of clinical signs of 
laminitis.  
Participation in this study was heavily influenced by contributions from 
veterinarians in Texas, as 19% of cases were contributed from veterinarians in this state. 
It is unlikely that this is because PEAL is a greater problem in Texas than in other parts 
of the country, but rather because there are many horses in Texas and because 
veterinarians might have felt a loyalty to study coordination at Texas A&M University. 
The effect of these potential response biases is unknown. As this study was limited to 
horses in North America, results should not be extrapolated globally because of regional 
differences in factors such as diet, management, and breeds of horses.  
 Information bias associated with misclassifying cases and controls was another possible 
limitation of this study. However, any misclassification would be expected to be non-
differential and thus bias our results toward the null. Diagnosis of laminitis for this study 
was made by equine veterinarians (i.e., members of the AAEP), rather than by horse 
owners, which likely reduced misclassification of cases and controls.  
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Another limitation of this study was the potential bias when selecting controls.  
Selection bias is a common bias inherent to case-control studies.81 To account for 
possible limitations of a single control population, 2 groups of controls were selected. 
While this is not uniformly accepted as a superior method to using a single control 
group, the finding of similar results between the 2 groups of controls strengthened the 
specificity of an associated factor for laminitis. Selection of cases may have also been 
biased by virtue of the name given to the disease, viz., pasture-and endocrinopathy-
associated laminitis (PEAL). The use of the title PEAL was not intended to include only 
horses with pasture-and endocrinopathy-associated disease, but rather to include any 
case of laminitis not attributed to grain overload, supporting-limb laminitis, or a septic 
process. Based on the low numbers of horses with a prior endocrinopathic diagnosis, it is 
suspected that the effect of this bias was limited. 
Finally, as with any epidemiologic study, the effect of confounding should be 
considered. Cases and controls were matched based on veterinarian in an effort to 
control for confounding on this variable. Bias introduced by measured variables were 
accounted for in the multivariable model, however, the association of PEAL may have 
been confounded by other factors that were unmeasured or not considered. 
In conclusion, this observational study revealed several important risk factors that might 
contribute to the development of PEAL. Identification of modifiable risk factors 
associated with incident laminitis indicates that preventing some cases of laminitis might 
be possible through implementation of therapeutic and managerial interventions and 
improved education of horse owners and veterinarians.  Studies to identify determinants 
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of obesity and adiposity and randomized, controlled interventions targeting these 
alterable risk factors is warranted, along with continued investigation of screening tests, 
treatments and other interventions that can ameliorate insulin regulation and obesity.  It 
is also plausible that earlier recognition and treatment of endocrinopathies might 
contribute to reducing the incidence of the devastating disease of laminitis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aSAS, SAS Institute Inc, Cary, NC. 
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CHAPTER IV  
SUMMARY AND CONCLUSIONS: RECOGNIZING AND UNDERSTANDING THE 
LIMITATIONS OF OBSERVATIONAL STUDIES 
Introduction 
As discussed in the first chapter of this dissertation, observational studies provide 
many clinically significant advantages over experimental studies, but are also fraught 
with inherent limitations.  The importance of recognizing and understanding these 
limitations cannot be overstated. The case-control study of laminitis and the 
retrospective, cohort study of R. equi pneumonia in foals described in this dissertation 
were very different in their design, methods of conduct, and analysis. The obstacles 
encountered at each stage of these 2 studies will be described in more depth here. 
Beyond the importance of recognizing the advantages and limitations of observational 
studies, this information is instructive by example for clinical scientists and students of 
epidemiology interested in conducting similar studies in the future. 
A Case-Control Study of Pasture-and Endocrinopathy-Associated Laminitis 
Materials and Methods 
In addition to selecting a design to answer the questions posed by the 
investigators, several other important considerations should be addressed prior to 
conducting a study. The design and method of administration of the questionnaire, the 
feasibility of collecting the data, financial resources, and availability of personnel should 
be considered. Addressing these concerns during early design of the study will improve 
study participation and the accuracy of the results. 82 
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An important obstacle in the design phase of an observational study is development of a 
questionnaire. Careful planning of the questionnaire is important to obtain quality data. 
83, 84 For the laminitis study, the questionnaire was designed by a panel of experts in the 
field of laminitis, with input from veterinary epidemiologists. Despite extensive work on 
the part of the panel and pilot testing prior to implementation, the questionnaire used in 
the laminitis study was imperfect. For example, the housing management section 
included open-questions regarding the hours per day the horse was kept in a stall or 
pasture. Four sequential questions were designed to capture the location of the horse 
over a 24-hour period (i.e. stall, large pasture, paddock, or drylot). Frequently, the 
answers to the 4 questions did not sum to 24 total hours. This was likely a result of 
several factors including confusing design of the questionnaire, misunderstanding of the 
questions by participants, and uncertainty or carelessness about the answer on the part of 
participants. Discrepancies were resolved through direct communication with the 
veterinarian, although the validity and reliability of their answers was unmeasured and is 
thus unknown.  
In human public health research, the method of administration of a questionnaire 
has been shown to have substantial effects on both the response rate and the quality of 
the data collected.85-87  Despite instructions that the veterinarian must complete the 
questionnaire, the method of administration of the questionnaire likely varied by 
veterinarian, with some veterinarians conducting in-person interviews with the horse-
owner and other veterinarians having the horse-owners complete the questionnaires 
themselves. Information regarding which person completed the survey was not captured.  
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The impact of this variation was likely small because the method of administration was 
generally similar by individual veterinarian, and was thus adjusted for in the analysis 
through matching of cases and controls by a particular veterinarian.  It is important to 
note that this would help control for potential confounding, but would not account for 
effect modification. 
Another potential source of bias in the laminitis study that could have been 
avoided during the design stage of the study was the title given to the study, viz., “A 
Case-Control Study of Pasture-and Endocrinopathic-Associated Laminitis.” Throughout 
the entire study period, there was frequent correspondence with the Study Coordinator 
(MCC) questioning the etiology of the laminitis cases that could be included in the 
study. The study intended to include any incident case of laminitis not caused by a septic 
process, contralateral weight-bearing, or grain overload. Participating veterinarians were 
often under the impression that only horses exposed to pasture or with an underlying 
endocrinopathy could be included in the study. Explicit inclusion and exclusion criteria 
for both cases and controls were provided to all participating veterinarians by email, 
regular mail, and on the website. Despite these efforts, the misleading title of the study 
appeared to over-ride the study definitions, resulting in a biased selection of cases. 
Interestingly, despite this perceived misconception, very few submitted cases had a prior 
diagnosis of an endocrinopathy.  
To ensure proper selection of cases and controls, clear and concise inclusion and 
exclusion criteria are essential.  The diagnostic criteria for a subject to become a case 
should be clearly defined and applied to all study subjects uniformly.  This study was 
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designed to determine risk factors for the development of incident cases of laminitis. A 
history of a prior laminitic episode was reported in 10 submitted cases. Additionally, 
control horses could not have a history of laminitis; however, 2 controls were submitted 
with a history of laminitis. These cases and controls were excluded from analysis.  
Selection of appropriate controls in case-controls studies is challenging.88,89 Controls are 
non-cases whose exposure of interest reflects the exposure in the source population.89 In 
the laminitis study, following identification of a laminitis case veterinarians identified a 
healthy control horse, intended to be the “next horse evaluated routinely by the 
veterinarian.” It is our belief that many of these control horses were either owned by the 
veterinarian themselves or by close friends/acquaintances of the veterinarians. Horses 
owned by veterinarians and their acquaintances are potentially managed differently than 
horses owned by the general population. This likely introduced a selection bias because 
the study group differed from the source population, biasing the association of the 
exposure and development of laminitis.  
Obtaining data from lameness controls was challenging with only 153 lameness 
controls submitted compared to 198 healthy controls. The healthy control was easy for 
veterinarians to identify. Data from cases and healthy controls were typically obtained 
with temporal proximity.  Follow-up communications with the veterinarian to remind 
them of the need for the lameness control were made at regular intervals; however, these 
attempts were frequently unsuccessful.   
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During the first 3 months of data collection, response rate was low: only 2 
veterinarians submitted data. Communications with submitting and participating 
veterinarians suggested that this time-frame was too stringent as many acute cases of 
laminitis were not recognized or evaluated for several days following the onset of 
clinical signs. Beginning in March of 2012, the case definition was adjusted to include 
horses within 4 weeks of the onset of clinical signs (Figure A-4.1a). Subsequent to this 
change, the submission rate appeared to improve substantially, though this may have 
been a result of other factors such as improved visibility of the study, the addition of an 
incentive for submission, or changes in the season (Figure A-4.1b). 
Results  
Conditional logistic regression was employed for analysis of this matched case-
control study, conditional upon an individual set submitted by a veterinarian. This 
method controls for confounding on the matched variable: the veterinarian. Using 
regular logistic regression by including dummy variables to represent the strata is 
possible; however, this approach to modeling only holds if the sample size is large 
relative to the number of parameters estimated.  
Limitations exist for CLR modeling, however. Coefficients cannot be estimated 
for constant predictors within matched sets using CLR. Again, in this study, the 
individual veterinarian was the constant predictor (factor). Although confounding by the 
constant predictor is accounted for in modeling by CLR, it is not possible to model effect 
modification.  Graphical methods exist for examining effect modification by the 
matching factor(s). 90  Finally, only sets in which a predictor varies within the set will 
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contribute to the estimation of the coefficient.  Consequently, missing observations in 
either the case or the control will exclude the set from analysis. Missing observations 
were infrequent in this study largely due to direct and tenacious communications 
between the Study Coordinator and the submitting veterinarians. As previously 
mentioned, the validity of the data provided by the veterinarian is unknown.  
One complication during analysis was the presence of contingency tables with cells 
having frequencies of 0. Standard logistic regression models fail to converge and thus 
produce a point-estimate of infinity when such complete separation exists.91 One 
solution is to use estimates derived by using exact methods to construct a statistical 
distribution that can be completely enumerated, but these are often time-consuming and 
impractical.92 Another suggested strategy for dealing with this problem is sensible 
collapse of categories for independent variables to eliminate the cell(s) with 0. 36 In the 
laminitis study, cells with values of 0 or very small numbers were encountered for 
several covariates. Within breed, there were no miniature horse controls. For this reason, 
breeds were collapsed based on breed similarities (e.g., miniature horses and ponies; 
draft horses and Warmbloods). Steroid administration was infrequent among all cases 
and controls, especially when stratified by the particular steroid administered. 
Consequently, all steroids were collapsed and dichotomized into horses that either 
received or did not receive recent steroids. The same method was employed for horses 
with a prior endocrinopathy, including pars pituitary intermedia dysfunction, equine 
metabolic syndrome, or insulin resistance. Although this solved the problem of obtaining 
an estimated odds ratio for the association with laminitis of either steroid use or 
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endocrinopathies, the small sample size still hampered our ability to effectively model 
and obtain results in which we could have confidence for these associations using 
multivariable modeling.   
Retrospective, Cohort Study of R. equi Pneumonia in Foals 
Materials and Methods  
The R. equi study was a retrospective, cohort study in which historical data were 
obtained from electronic medical records (EMRs) of a large breeding farm. The use of 
EMRs is desirable from the standpoint of immediate availability, ease of obtaining data, 
and reduced costs; however, these records are designed to support health care provision, 
and are not structured necessarily in a way to facilitate clinical research. As a result, 
there are several limitations to this method of data collection.  
First, the quality of the study relied on the quality of the EMRs. Data were 
entered into the EMRs by a variety of people, including veterinarians, veterinary 
technicians, veterinary students, farm personnel, and office administrators. The accuracy 
and validity of the records was not assessed. All data extractions were performed by a 
single investigator; however, transcription of the data from the EMRs to the research 
database had potential for error and non-differential misclassification.  
Accessing the EMRs in this study was also problematic. Remote access was 
provided to only 1 computer at the farm, and if the computer was actively being used by 
farm personnel, concurrent data collection was not possible. During normal business 
hours, obtaining data was nearly impossible and thus the progress of the study was 
delayed. 
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The EMRs system contained over 16,000 medical records. Individual foal 
records were identified using foaling reports generated by the farm, which included 
many foals with blank records. The EMRs for these foals were accessed as there was no 
way to predict which records contained valuable information. This was a very time-
consuming with no benefit. It is likely that this method of selecting cases and non-cases 
resulted in selection bias, although the magnitude and direction this bias might have on 
estimated associations is unknown.  
Selection of the years of data included in the study was based on farm practices. 
Initially, data were collected from 2009-2013, but only the 2009-2011 foals were 
included in the study. Beginning in 2012, foals were routinely evaluated sonographically 
for the presence of pulmonary abscessation consistent with R. equi pneumonia. Foals 
with sonographic changes, even in the absence of clinical signs, were treated with 
antimicrobials.  Because this practice represented a change in case definition/diagnostic 
and therapeutic practices, data from these years were excluded from analysis for this 
particular study. It would be interesting to compare risk factors identified during years in 
which screening practices were implemented compared to years in which no screening 
was performed, although it will be impossible to separate effects of calendar time from 
diagnostic and therapeutic practices. 
Results 
In addition to the aforementioned selection and information bias, the R. equi 
study was subject to a final and important form of bias, viz., confounding.  A confounder 
is a risk factor for the disease of study which is associated with the exposure of interest, 
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although not part of the causal pathway (Figure A-4.2). Confounders that are not 
considered in the design or analysis of a study can result in a biased estimate of the 
association of a risk factor with disease. Confounding variables can be addressed in a 
number of ways including consideration of potential confounders in the design of the 
study (i.e., matching) and accounting for them in the statistical analysis. An excellent 
example of confounding was present in the R. equi study (Figure A-4.3). Foals receiving 
2 liters of hyperimmune plasma (HIP) within the first 24 hours after birth appeared less 
likely to develop R. equi pneumonia compared to foals receiving 1 liter within 24 hours 
(Table A-4.1, Figure A-4.4). However, both the cumulative incidence of disease on the 
farm (Table A-4.2, Figure A-4.5) and the method of HIP administration varied by year 
(Table A-4.3, Figure A-4.6).  When the method of HIP administration was stratified by 
year, there was no effect of the volume of plasma transfusion on the development of 
pneumonia (Table A-4.4, Figure A-4.7a and Figure A-4.7b). In this example, year is a 
confounder for the effect of HIP administration on the development of R. equi 
pneumonia because it was a risk factor for development of disease and was associated 
with the method of HIP administration (but disease was not a result of the method of 
administration).  
Conclusions and Future Work 
Despite the limitations of these observational studies, valuable information was 
obtained which may direct future research efforts. The case-control study of laminitis 
identified several important modifiable risk factors that might contribute to the 
development of disease. Identification of modifiable risk factors (e.g., control of obesity) 
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associated with incident laminitis indicates that prevention of some cases of laminitis 
may be possible through implementation of therapeutic and managerial interventions and 
improved education of horse owners. Randomized, controlled interventions targeting 
these alterable factors is warranted. In the cohort study of R. equi a variation in clinical 
incidence among years at breeding farms was noted. This finding is worthy of 
investigation. Furthermore, the finding that foals with a prior disease are less susceptible 
to R. equi pneumonia might lead to strategies for immunoprophylaxis. Ultimately, these 
studies highlighted the importance of recognizing potential risk factors for development 
of disease that may guide future studies into the control and prevention of disease. 
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APPENDIX 1 
 
Figure A-1.1. Schematic of the advantages and disadvantages of the different types of 
observational study designs. 
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Figure A-1.2. Diagram of confounding variables for cohort study of Rhodococcus equi 
pneumonia in foals 
 
 
 
 
 
 
 
 
 
Figure A-1.3. Observed association between HIP administration and R. equi pneumonia 
for cohort study of R. equi pneumonia in foals 
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Figure A-1.4. Distribution of cases and non-cases by year for cohort study of R. equi 
pneumonia in foals 
 
 
 
Figure A-1.5. Distribution of method of HIP plasma administration by year for cohort 
study of R. equi pneumonia in foals 
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Figure A-1.6. Method of HIP administration stratified by year for year A (A) and year B 
(B). 
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Figure A-1.7. Hierarchy of populations from a cohort study of R. equi pneumonia in 
foals 
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APPENDIX 2 
Figure A-2.1. Flow diagram of the study population used in a cohort study of R. equi 
pneumonia in foals 
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Table A-2.1. Cumulative incidence of disease on farm by year 
Year Number of cases Number of non-
cases 
Total number 
of foals 
Proportion of 
foals with 
disease 
2009 40 205 245 16% 
2010 124 148 272 46% 
2011 45 225 270 17% 
 
 
Figure A-2.2. Proportion of cases and non-cases by year 
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Table A-2.2. Proportion of foals affected by birth-month 
Month Number of cases Number of non-
cases 
Total number 
of foals 
Proportion of 
foals with 
disease 
January 11 56 68 16% 
February 45 103 147 30% 
March 71 178 249 29% 
April 50 174 224 22% 
May 31 66 97 31% 
June 1 1 2 50% 
 
 
 
Table A-2.3. Results of bivariate logistic regression analysis of potential foal-level risk 
factors for R. equi pneumonia in foals among 788 foals on a breeding farm in Texas in 
which disease was endemic.  
Category Variable Frequency 
of Cases 
Proportion 
of Cases 
Frequency 
of Non-
Cases 
Propor
-tion of 
Non-
Cases 
Bi-
variable 
OR 
Bi-
vari
able 
95% 
CI 
Bi-
variable 
P-value 
Year         
 2009 and 2011 85/209 41 430/578 75 1.0   
 2010 124/209 59 148/578 26 4.2 3.0-
5.9 
<0.001 
         
Season         
 January-
March 
71/209 59 178/578 31 1.0   
 April-June 138/209 41 400/578 69 0.9 0.6-
1.2 
0.39 
         
Gestation         
(days) ≥ 325 202/209 97 545/578 94 1.0   
 <325 7/209 3 33/578 6 0.6 0.2-
1.3 
0.18 
         
Dam age          
(years) ≤10 114/209 55 314/578 54 1.0   
 >10 98/209 45 264/578 46 1.0 0.7-
1.4 
0.95 
         
Foals 
carried by 
biological 
dam 
        
 No 123/209 59 379/577 66 1.0   
 Yes 86/209 41 198/577 34 1.4 1.0-
1.8 
0.08 
         
Sex         
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 Colt 111/209 53 308/578 53 1.0   
 Filly 98/209 47 270/578 47 1.0 0.7-
1.4 
0.96 
         
Intended 
use 
        
 Race 115/209 55 275/578 48 1.0   
 Ranch 94/209 45 303/578 52 0.8 0.6-
1.0 
0.08 
         
Foaling 
location 
        
 Stall 117/209 56 275/578 48 1.0   
 Pasture 92/209 44 303/578 52 0.7 0.5-
1.0 
0.04 
         
IgG         
 <800 15/160 9 37/324 11 1.0   
 ≥ 800 145/160 91 287/324 89 1.3 0.66
-
2.35 
0.49 
         
Comorbidit
y 
        
 No 185/206 90 434/566 77 1.0   
 Yes 21/206 10 132/566 23 0.4 0.2-
0.6 
<0.001 
         
Prior 
respiratory 
infection 
        
 No 207/209 99 556/578 96 1.0   
 Yes 2/209 1 22/578 4 0.2 0.1-
1.0 
0.05 
         
Prior 
antimicrobi
al 
administrati
on 
        
 No 96/207 46 267/565 47 1.0   
 Yes 111/207 54 298/565 53 1.1 0.8-
1.4 
0.82 
         
Penicillin/ 
gentamicin 
for 3 days 
        
 No 107/207 52 355/563 63 1.0   
 Yes 100/207 48 208/563 37 1.6 1.2-
2.2 
0.004 
         
Plasma 
transfusion 
        
 1 L 124/207 60 198/558 35 1.0   
 2L 83/207 40 360/558 65 0.4 0.3-
0.5 
<0.001 
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Table A-2.4. Results of trivariate logistic regression analysis including year of potential 
foal-level risk factors for R. equi pneumonia in foals among 788 foals on a breeding 
farm in Texas in which disease was endemic. 
 
Category Variable Frequenc
y Cases 
Propor
tion 
Cases 
Frequenc
y Non-
Case 
Proportion 
Non-Case 
Tri-
variable 
OR 
Tri-variable 
95%  CI 
Tri-
variable 
P-value 
         
Season         
 January-
March 
71/209 59 178/578 31 1.0   
 April-
June 
138/209 41 400/578 69 0.9 0.6-1.3 0.53 
         
Gestation         
(days) ≥ 325 202/209 97 545/578 94 1.0   
 <325 7/209 3 33/578 6 0.7 0.3-1.6 0.37 
         
Dam age         
(years) ≤10 114/209 55 314/578 54 1.0   
 >10 98/209 45 264/578 46 1.0 0.7-1.7 0.96 
         
Foals 
carried by 
biological 
dam 
        
 No 123/209 59 379/577 66 1.0   
 Yes 86/209 41 198/577 34 1.2 0.9-1.7 0.23 
         
Sex         
 Colt 111/209 53 308/578 53 1.0   
 Filly 98/209 47 270/578 47 1.0 0.7-1.3 0.93 
         
Intended 
use 
        
 Race 115/209 55 275/578 48 1.0   
 Ranch 94/209 45 303/578 52 0.8 0.6-1.1 0.17 
         
 
Foaling 
location 
        
 Stall 117/209 56 275/578 48 1.0   
 Pasture 92/209 44 303/578 52 0.8 0.5-1.0 0.09 
         
IgG         
 <800 15/160 9 37/324 11 1.0   
 ≥ 800 145/160 91 287/324 89 1.0 0.5-2.0 0.91 
         
Comorbidit
y 
        
 No 185/206 90 434/566 77 1.0   
 Yes 21/206 10 132/566 23 0.4 0.23-.64 <0.001 
         
Prior 
respiratory 
infection 
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 No 207/209 99 556/578 96 1.0   
 Yes 2/209 1 22/578 4 0.1 0.0-0.5 <0.001 
         
Prior 
antimicrobi
al 
administrati
on 
        
 No 96/207 46 267/565 47 1.0   
 Yes 111/207 54 298/565 53 0.9 0.65-1.29 0.64 
         
Penicillin/ 
gentamicin 
for 3 days 
        
 No 107/207 52 355/563 63 1.0   
 Yes 100/207 48 208/563 37 1.5 1.1-2.1 0.02 
         
Plasma 
administrati
on 
        
 1 L 124/207 60 198/558 35 1.0   
 2L 83/207 40 360/558 65 1.5 0.8-2.8 0.21 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 80 
 
Table A-2.5. Differences in foaling location of race-versus ranch-bred foals 
 
 Number of foals 
included in study 
Foaled 
in stall 
Foaled in 
pasture 
Race-bred foals 393/788 (50%) 387 (99%) 6 (1%) 
 
Ranch-bred foals 395/788 (50%) 6 (2%) 389 (98%) 
 
 
Table A-2.6. Number and proportion of cases and non-cases with a comorbidity during 
the 3 years of the study 
 
 Number (%) of cases 
with comorbidity 
Number (%) of non-cases 
with comorbidity 
2009 7/40 
(17.5%) 
48/205 
(23%) 
 
2010 10/124 
(8%) 
35/148 
(24%) 
 
2011 4/42 
(10%) 
49/213 
(23%) 
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Table A-2.7. Number and proportion of cases and non-cases with an RTI during the 3 
years of the study 
 Number (%) of cases with an RTI Number (%) of non-cases with an 
RTI 
2009 0/40 
(0%) 
2/205 
(1%) 
 
2010 2/124 
(2%) 
18/148 
(12%) 
 
2011 0/45 
(0%) 
2/225 
(1%) 
 
 
 
Table A-2.8. Method of HIP administration by year 
 1 L HIP within 24 hours 2 L within 24 hours 1 L within 24 hours, 1 
L at 21 days 
2009 11/243 
(3%) 
178/243 
(73%) 
58/243 
(24%) 
 
2010 126/271 
(46%) 
15/271 
(6%) 
 
130/271 
(48%) 
2011 1/251 
(1%) 
250/251 
(99%) 
0 
(0%) 
 
 
Table A-2.9. Multivariable model of variables significantly associated with a foal 
developing R. equi pneumonia 
 
Category Variable OR 95 % CI P-value 
Year     
 2009 and 2011 1.0   
 2010 3.6 2.4-5.6 <0.001 
Comorbidity     
 No 1.0   
 Yes 0.3 0.2-0.6 < 0.001 
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APPENDIX 3 
Figure A-3.1. Flow diagram of study design for a case-control study of pasture- and 
endocrinopathic- associated laminitis in horses 
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Figure A-3.2. Flow diagram of the recruitment of cases and controls into the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7,100 directly recruited veterinarians 
625 veterinarians registered to participate 
Response rate = 9% 
115 veterinarian submitted questionnaires 
Response rate = 18% 
550 usable responses 
9 cases evaluated greater than 4 
weeks within onset of clinical signs 
10 cases of chronic laminitis 
5 history of laminitis unknown 
5 very incomplete questionnaires 
6 duplicate questionnaires 
2 controls with history of laminitis 
4 controls with no submitted case 
11 lameness controls with chronic 
lameness 
199 case-control sets 
109 veterinarian submissions 
included 
52 ineligible responses 
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Figure A-3.3. Distribution of cases and controls by geographic location in the United 
States and Canada. 
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Figure A-3.4.  Distribution of season of onset of clinical signs for cases of PEAL. 
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Figure A-3.5. Proportion of Obel grade of lameness for cases of PEAL 
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Figure A-3.6.  Proportion of etiology of lameness for lameness controls 
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Table A-3.1. Number and proportions of cases of PEAL and healthy and lameness 
controls for each variable 
 Variable % 
Cases 
Number 
of cases 
% 
Health
y 
control
s 
Numbe
r of 
healthy 
controls 
% 
Lamenes
s 
controls 
Number 
lamenes
s 
controls 
        
SIGNALMENT 
 
       
Breed        
 Quarter 
Horse/Paint/Appaloosa 
38 73 45 89 50 77 
 Thoroughbred 6 12 15 30 18 28 
 Arabian 11 21 8 16 7 11 
 Morgan 6 11 2 4 1 2 
 Draft/Warmblood 9 17 15 30 12 19 
 Gaited Horses 9 17 6 12 5 7 
 Miniatures/Ponies 13 25 1 2 1 2 
 Other Breeds 8 16 8 16 5 7 
        
        
Age        
 < 20 years 84 168 83 164 89 136 
 ≥ 20 years 16 31 17 34 11 17 
        
Gender        
 Mare 50 100 44 87 42 64 
 Gelding 46 91 54 107 54 93 
 Stallion 4 8 2 4 4 6 
BODY CONDITION        
BCS        
 BCS <7 34 67 83 165 81 124 
 BCS>=7 66 132 17 33 19 29 
        
Neck Circumference        
 ≤ 36 inches 20 39 23 45 27 41 
 36.1 to 38 inches 16 31 21 42 23 35 
 38.1 to 41 inches 23 45 34 68 31 47 
 ≥ 41.1 inches 42 84 22 43 20 30 
        
Height        
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 ≤ 14.2 hands 31 62 19 36 16 24 
 >14.2 hands 69 136 81 155 84 125 
        
Girth:Height Ratio         
 ≤0.07 71 36 44 82 43 66 
 0.071 to 0.08 22 22 17 33 17 26 
 0.081 to 0.1 51 26 25 50 37 37 
 ≥ 0.11 55 28 17 33 24 24 
        
General and/or 
Regional Adiposity 
       
 No 24 47 75 149 73 111 
 Yes 76 152 25 49 27 42 
        
Cresty Neck        
 No 38 75 82 163 85 130 
 Yes 62 124 18 35 15 23 
        
Adiposity at Tailhead        
 No 44 88 86 171 87 133 
 Yes 56 111 14 27 13 20 
        
Ventral Adiposity        
 No 83 166 96 190 98 150 
 Yes 17 33 4 8 2 3 
        
Flank Adiposity        
 No 85 169 97 193 97 148 
 Yes 15 30 3 5 3 5 
        
Thoracic Adiposity        
 No 76 152 93 184 93 142 
 Yes 23 47 7 14 7 11 
        
Periorbital Adiposity        
 No 84 167 98 195 98 150 
 Yes 16 32 2 3 2 3 
        
ACTIVITY        
Frequency of Exercise        
 Not regular 67 134 52 102 48 73 
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 1-2 x per week 14 28 19 38 18 27 
 3-4 x per week 12 23 16 32 20 30 
 5-6 x per week 7 13 12 23 13 20 
 >6 x per week 0.5 1 2 3 2 3 
        
Intensity of Exercise        
 None 62 123 45 90 46 70 
 Low 29 57 33 65 32 48 
 Moderate 8 16 19 37 20 31 
 High 2 3 3 6 3 4 
        
Recent Change in 
Activity 
       
 No 87 173 92 182 90 137 
 Yes 13 26 8 16 10 16 
        
STABLING        
Exclusively Stalled        
 No 97 193 99 196 97 148 
 Yes 3 6 1 2 3 5 
        
Recent Change of 
Stabling 
       
 No 85 169 186 94 94 143 
 Yes 15 29 12 6 6 9 
        
Type of Stabling 
Change 
       
 Increased stall 38 11 33 4 44 4 
 Increased grass 45 13 50 6 44 4 
 Decreased grass at 
turnout 
17 5 17 2 11 1 
        
Acreage of Pasture        
 ≤ 3 acres 56 110 54 107 59 90 
 >3 acres 44 88 46 91 41 63 
        
Size of Herd        
 ≤ 3 horses 70 139 68 134 65 99 
 >3 horses 30 60 32 64 35 54 
        
History of Laminitis in 
Pasture 
       
 No 87 162 90 170 92 130 
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 Yes 13 24 10 18 8 11 
        
Quality  of Grass        
 No grass to limited 
grass 
26 47 37 72 38 56 
 Mild to high growth 74 136 63 121 62 91 
        
Pastures Mowed for 
Grass 
       
 No 44 74 53 98 54 68 
 Yes 56 94 47 86 46 59 
        
Pastures Mowed for 
Weeds 
       
 No 40 66 37 66 41 53 
 Yes 60 101 63 114 59 75 
        
Pastures Fertilized        
 No 85 137 75 135 81 104 
 Yes 15 25 25 44 19 24 
        
Herbicides Applied to 
Pastures 
       
 No 92 145 91 164 95 118 
 Yes 8 13 9 16 5 6 
        
DIET        
Concentrates Included 
in Diet 
       
 No 33 57 24 43 20 29 
 Yes     67 115 76 136 80 114 
        
Hay Included in Diet        
 No 20 41 20 40 21 32 
 Yes 80 158 80 158 79 121 
        
Recent Change in Diet        
 No 90 179 96 190 96 147 
 Yes 10 20 4 8 4 6 
        
Metabolic Disease        
Diagnosed with Prior 
Endocrinopathy 
       
 No 74 147 93 184 93 142 
 Yes 26 52 7 14 7 11 
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Pregnant        
 No 97 142 97 140 97 110 
 Yes 3 4 3 4 3 3 
        
Lactating        
 No 97 141 95 136 99 113 
 Yes 3 5 5 7 1 1 
        
TRAVEL        
Travel >4 Hours        
 No 98 165 98 195 97 146 
 Yes 2 3 2 3 3 5 
        
FARRIER CARE        
 Type of Farrier Care         
 None in 6 months 7 14 4 7 3 5 
 Trim only 63 125 59 118 54 81 
 Front shoes 11 22 11 21 16 24 
 All shoes 19 37 26 52 27 41 
        
Frequency  of Farrier 
Care 
       
 ≤ every 6 weeks 53 105 59 115 57 87 
 > every 6 weeks 47 93 41 83 43 66 
        
Duration since Last 
Farrier Care 
       
 Within 4 weeks 63 124 66 130 70 106 
 More than 4 weeks prior 37 74 34 68 30 47 
        
Farrier within 1 week        
 Within 1 week 20 40 22 44 19 29 
 Greater than 1 week 80 159 78 154 81 124 
        
GLUCOCORTICOI
DS 
       
Administered within 
30 Days 
       
 No 94 186 98 194 99 150 
 Yes 6 12 2 4 1 1 
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Table A-3.2. Bivariable conditional logistic regression comparing cases of PEAL to 
healthy controls. 
 
 Variable Odds Ratio 95% CI P Value 
SIGNALMENT     
Breed     
 Thoroughbred 0.33 0.13-0.85 <.0001 
 Quarter Horse/Paint/ 
Appaloosa 
Reference   
 Arabian 1.77 0.8-3.87 0.80 
 Morgan 3.54 0.89-14.01 0.32 
 Draft/Warmblood 0.62 0.28-1.37 0.003 
 Gaited Horses 3.00 1.05-8.56 0.34 
 Miniatures/Ponies 30.89 3.93-242.71 0.002 
 Other Breeds 1.62 0.63-4.16 0.68 
     
     
Age     
 < 20 years Reference   
 ≥ 20 years 0.57 0.17-1.95 0.37 
     
Gender     
 Mare Reference   
 Gelding 0.72 0.47-1.10 0.09 
 Stallion 1.70 0.50-5.77 0.26 
     
BODY CONDITION     
BCS     
 BCS <7 Reference   
 BCS≥7 12.00 6.08-23.69 <.0001 
     
Neck Circumference     
 ≤ 36 inches Reference   
 36.1 to 38 inches 0.78 0.41-1.49 0.10 
 38.1 to 41 inches 0.84 0.45-1.56 0.13 
 ≥ 41.1 inches 2.18 1.19-3.98 <.0001 
     
Height     
 ≤ 14.2 hands    
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 >14.2 hands 0.45 0.26-0.78 0.004 
     
Girth:Height Ratio      
 ≤0.07 Reference   
 0.071 to 0.08 0.79 0.42-1.52 0.09 
 0.081 to 0.1 1.17 0.70-1.94 0.99 
 ≥ 0.11 1.99 1.12-3.48 0.01 
     
General and/or Regional 
Adiposity 
    
 No Reference   
 Yes 9.50 5.24-17.22 <.0001 
     
Cresty Neck     
 No Reference   
 Yes 8.42 4.63-15.30 <.0001 
     
Adiposity at Tailhead     
 No Reference   
 Yes 8.64 4.62-16.12 <.0001 
     
Ventral Adiposity     
 No Reference   
 Yes 5.80 2.25-14.98 0.0003 
     
Flank Adiposity     
 No Reference   
 Yes 7.25 2.55-20.62 0.0002 
     
Thoracic Adiposity     
 No Reference   
 Yes 6.50 2.75-15.35 <.0001 
     
Periorbital Adiposity     
 No Reference   
 Yes 10.67 3.26-34.83 <.0001 
     
ACTIVITY     
Frequency of Exercise      
 Not regular Reference   
 1-2 x per week 0.56 0.32-1.01 0.73 
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 3-4 x per week 0.49 0.26-0.93 0.91 
 5-6 x per week 0.43 0.21-0.90 0.65 
 >6 x per week 0.28 0.03-2.80 0.54 
     
Intensity of Exercise     
 None Reference   
 Low 0.65 0.39-1.05 0.26 
 Moderate 0.34 0.18-0.64 0.25 
 High 0.23 0.04-1.29 0.27 
     
Recent Change in 
Activity  
    
 No Reference   
 Yes 1.64 0.84-3.19 0.14 
STABLING     
Exclusively Stalled     
 No Reference   
 Yes 3.00 0.61-14.80 0.18 
     
Recent Change of 
Stabling 
    
 No Reference   
 Yes 3.12 1.40-6.93 0.005 
     
Type of Stabling Change     
 Increased stall Reference   
 Increased grass 1.13 0.34-3.69 0.78 
 Decreased grass at 
turnout 
0.93 0.18-4.75 0.85 
     
Acreage of Pasture     
 ≤ 3 acres Reference   
 >3 acres 0.92 0.59-1.4 0.73 
     
Size of Herd     
 ≤ 3 horses Reference   
 >3 horses 0.89 0.59-1.42 0.63 
     
History of Laminitis in 
Pasture 
    
 No Reference   
 Yes 1.58 0.79-3.26 0.21 
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Quality of Grass     
 No grass to limited 
grass 
Reference   
 Mild to high growth 1.80 1.12-2.92 0.02 
     
Pastures Mowed for 
Grass 
    
 No Reference   
 Yes 1.80 1.06-3.08 0.03 
     
Pastures Mowed for 
Weeds 
    
 No Reference   
 Yes 0.78 0.44-1.37 0.38 
     
Pastures Fertilized     
 No Reference   
 Yes 0.62 0.35-1.12 0.11 
     
Herbicides Applied to 
Pastures 
    
 No Reference   
 Yes 0.90 0.38-2.14 0.82 
     
DIET     
Concentrates Included in 
Diet 
    
 No Reference   
 Yes 0.55 0.30-1.02 0.06 
     
Hay Included in Diet     
 No Reference   
 Yes 0.95 0.54-1.69 0.88 
     
Recent Change in Diet     
 No Reference   
 Yes 2.50 1.1-5.67 0.02 
     
METABOLIC 
DISEASE 
    
Diagnosed with Prior 
Endocrinopathy 
    
 No Reference   
 Yes 10.50 3.76-29.28 <0.0001 
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Pregnant     
 No Reference   
 Yes 0.75 0.16-3.35 0.71 
     
Lactating     
 No Reference   
 Yes 0.57 0.17-1.95 0.37 
     
TRAVEL     
Travel >4 Hours     
 No Reference   
 Yes 1.00 0.20-4.90 1.00 
     
FARRIER CARE     
Type of Farrier Care     
 None in 6 months Reference   
 Trim only 0.47 0.16-1.37 0.72 
 Front shoes 0.44 0.13-1.59 0.66 
 All shoes 0.31 0.11-.96 0.03 
     
Frequency of Farrier Care     
 ≤ every 6 weeks Reference   
 > every 6 weeks 1.29 0.82-2.00 0.26 
     
Duration since Last 
Farrier Care 
    
 Within 4 weeks Reference   
 More than 4 weeks 
prior 
1.17 0.75-1.80 0.50 
     
Farrier within  1 Week     
 Within 1 week Reference   
 Greater than 1 week 1.13 0.69-1.85 0.62 
     
GLUCOCORTICOIDS     
Administered within 30 
Days 
    
 No Reference   
 Yes 3.00 0.96-9.30 0.06 
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Table A-3.3. Bivariable conditional logistic regression comparing cases of PEAL to 
lameness controls. 
 
 Variable Odds 
Ratio 
95% CI P Value 
SIGNALMENT         
Breed        
 Quarter 
Horse/Paint/Appaloosa 
Reference   
 Thoroughbred 0.44 0.17-1.17 0.0002 
 Arabian 2.67 0.94-7.55 0.71 
 Morgan 7.18 1.30-42.02 0.13 
 Draft/Warmblood 1.32 0.49-2.86 0.09 
 Gaited Horses  2.73 0.87-8.47 0.71 
 Miniatures/Ponies 9.55 2.58-35.39 0.01 
 Other Breeds 2.72 1.04-7.11 0.68 
       
       
Age         
 < 20 years Reference    
 ≥ 20 years 1.5 0.76-2.95 0.24 
       
Gender         
 Mare Reference    
 Gelding 0.75 0.45-1.20 0.59 
 Stallion 0.81 0.22-2.96 0.93 
       
BODY CONDITION         
BCS         
 BCS <7 Reference    
 BCS>=7 16.00 6.48-39.49 <.0001 
       
Neck Circumference         
 ≤ 36 inches Reference    
 36.1 to 38 inches 0.59 0.28-1.25 0.01 
 38.1 to 41 inches 1.02 0.53-1.97 0.49 
 ≥ 41.1 inches 3.19 1.59-6.41 <.0001 
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Height         
 ≤ 14.2 hands       
 >14.2 hands 0.33 0.16-0.66 0.001 
       
Girth:Height Ratio         
 ≤0.07 Reference    
 0.071 to 0.08 0.51 0.19-1.33 0.02 
 0.081 to 0.1 1.20 0.65-2.24 0.71 
 ≥ 0.11 2.43 1.28-4.63 0.001 
     
General and/or Regional 
Adiposity 
        
 No Reference    
 Yes 11.85 5.49-25.65 <.0001 
       
Cresty Neck         
 No Reference    
 Yes 10.50 5.08-21.68 <.0001 
       
Adiposity at Tailhead         
 No Reference    
 Yes 11.50 4.99-26.49 <.0001 
       
Ventral Adiposity         
 No Reference    
 Yes 24.00 3.25-177.41 0.001 
       
Flank Adiposity         
 No Reference    
 Yes 7.67 2.30-25.53 0.0009 
       
Thoracic Adiposity         
 No Reference    
 Yes 5.67 2.38-13.49 <.0001 
       
Periorbital Adiposity         
 No Reference    
 Yes 12.50 2.96-52.77 0.0006 
       
ACTIVITY         
Frequency of Exercise         
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 Not regular Reference    
 1-2 x per week 1.96 0.97-3.90 0.79 
 3-4 x per week 1.92 0.38-6.17 0.82 
 5-6 x per week 1.06 0.59-1.51 0.98 
 >6 x per week 0.39  .04-2.11  0.91 
       
Intensity of Exercise         
 None Reference    
 Low 0.59 0.36-1.03 0.61 
 Moderate 0.23 0.09-0.53 0.03 
 High 0.50 0.09-2.73 0.98 
       
Recent Change in 
Activity 
        
 No Reference    
 Yes 1.50 0.76-2.95 0.23 
       
STABLING         
Exclusively Stalled         
 No Reference    
 Yes 0.81 0.22-2.97 0.74 
       
Recent Change of 
Stabling 
        
 No Reference    
 Yes 5.25 1.80-15.29 0.002 
       
Type of Stabling Change         
 Increased stall      
 Increased grass 1.18 0.24-5.86 0.87 
 Decreased grass at turnout 1.82 0.16-20.71 0.66 
       
Acreage of Pasture         
 ≤ 3 acres Reference    
 >3 acres 1.09 0.67-1.76 0.71 
       
Size of Herd         
 ≤ 3 horses Reference    
 >3 horses 0.76 0.47-1.24 0.27 
       
History of Laminitis in 
Pasture 
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 No Reference    
 Yes 1.64 0.77-3.47 0.19 
       
       
Quality of Grass         
 No grass to limited grass Reference    
 Mild to high growth 1.92 1.06-3.54 0.03 
       
Pastures Mowed for 
Grass 
        
 No Reference    
 Yes 2.25 1.14-4.44 0.02 
       
Pastures Mowed for 
Weeds 
        
 No Reference    
 Yes 1.28 0.69-2.37 0.43 
       
Pastures Fertilized         
 No Reference    
 Yes 0.47 0.37-1.57 0.47 
       
Herbicides Applied to 
Pastures 
        
 No Reference    
 Yes 2.50 0.78-7.97 0.12 
       
DIET         
Concentrates Included in 
Diet 
        
 No Reference    
 Yes 0.42 0.20-.82 0.01 
       
Hay Included in Diet         
 No Reference    
 Yes 1.04 0.59-1.82 0.88 
       
Recent Change in Diet         
 No Reference    
 Yes 3.25 1.06-9.97 0.04 
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METABOLIC 
DISEASE 
Diagnosed with Prior 
Endocrinopathy 
    
 No Reference   
 Yes 10.00 1.30-78.01 0.03 
Pregnant         
 No Reference    
 Yes 1.00 0.14-7.10 1.00 
       
Lactating         
 No Reference    
 Yes 2.22 0.18-22.06 0.57 
       
TRAVEL         
Travel >4 Hours         
 No Reference    
 Yes 0.60 0.14-2.50 0.48 
       
FARRIER CARE         
Type of Farrier Care         
 None in 6 months Reference    
 Trim only 0.54 0.13-2.13 0.52 
 Front shoes 0.29 0.06-1.34 0.14 
 All shoes 0.29 0.07-1.20 0.07 
       
Frequency  of Farrier 
Care 
         
 ≤ every 6 weeks Reference    
 > every 6 weeks 1.29 0.81-2.37 0.23 
       
Duration since Last 
Farrier Care 
        
 Within 4 weeks Reference    
 More than 4 weeks prior 1.35 0.83-2.18 0.23 
       
Farrier within 1 Week         
 Within 1 week Reference    
 Greater than 1 week 1.14 0.63-2.05 0.66 
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GLUCOCORTICOIDS 
Administered within 30 
Days 
        
 No Reference    
 Yes 10.00 1.28-78.12 0.03 
 
 
 
Table A-3.4. Results of multivariable conditional logistic regression comparing cases of 
PEAL to healthy controls. 
 
Variable  Odds Ratio 95% CI P Value 
Body Condition 
Score 
    
 BCS <7 Reference   
 BCS≥7 3.24 1.22-8.58 0.02 
     
Generalized 
and/or Regional 
Adiposity 
    
 No Reference   
 Yes 5.21 1.86-14.55 0.002 
     
Concentrates 
Included in Diet 
    
 No Reference   
 Yes 0.84 0.73-0.96 0.01 
     
Diagnosed 
Previously with 
Endocrinopathy 
    
 No Reference   
 Yes 5.65 1.32-24.27 0.02 
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Table A-3.5. Results of multivariable conditional logistic regression comparing cases of 
PEAL to lameness controls. 
 
Variable  Odds Ratio 95% CI P-Value 
Body Condition 
Score 
    
 BCS <7 Reference   
 BCS≥7 4.73 1.45-15.37 0.01 
     
Generalized 
and/or Regional 
Adiposity 
    
 No Reference   
 Yes 3.65 1.23-10.79 0.01 
     
Diagnosed 
Previously with 
Endocrinopathy 
    
 No Reference   
 Yes 2.71 1.7-7.28 0.04 
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APPENDIX 4 
Figure A-4.1a. Number of case submissions by month in 2012 in the case-control study 
of pasture-and endocrinopathy-associated laminitis (PEAL)  
 
Figure A-4.1b. Number of case submissions by month in 2012-2015 in the PEAL study  
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Figure A-4.2. Schematic of confounding 
 
 
 
 
 
 
 
 
 
 
Figure A-4.2. Diagram of confounding variables for cohort study of Rhodococcus equi (R. equi) 
pneumonia in foals 
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Table A-4.1. Distribution of cases and non-cases by year for cohort study of R. equi 
pneumonia in foals displaying that year is a risk factor for disease 
Year                      Case Non-Case 
2009/2011 85/515 (17%) 430/515 (83%) 
2010 124/272 (46%) 148/272 (54%) 
Total 209 578 
 
 
Figure A-4.4. Distribution of cases and non-cases by year for cohort study of R. equi 
pneumonia in foals 
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Table A-4.2. Distribution of method of hyperimmune plasma (HIP) administration by 
year for cohort study of R. equi pneumonia in foals displaying that year is associated 
with HIP administration method 
 
Year Total 1 L HIP 2 L HIP 
2009/2011 494 66 (13%) 428 (87%) 
2010 271 256 (94%) 15 (6%) 
 
 
Figure A-4.5. Distribution of method of HIP plasma administration by year for cohort 
study of R. equi pneumonia in foals 
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Table A-4.3. Observed Association between HIP administration and R. equi pneumonia 
for cohort study of R. equi pneumonia in foals 
Exposed Case Non-Case Odds Ratio 
2 L 83 360 (83*198)/(124*360)= 
0.37 1 L 124 198 
Total 207 558 
    
Foals receiving 2L of HIP during first 24 hours after birth are less likely to develop 
R. equi pneumonia compared to foals receiving 1L.  
 
 
Figure A-4.6. Observed Association between HIP administration and R. equi pneumonia 
for cohort study of R. equi pneumonia in foals 
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Table A-4.4. Stratification of HIP Administration among vases and non-cases by year 
for cohort study of R. equi pneumonia in foals 
Year Exposure Case Non-Case Odds Ratio 
2009/2011 2 L 76 352  
(76*59)/(7*352)=1.8 1 L 7 59 
Total 83 411  
2010 2 L 7 8  
(7*139)/(8*117)=1 1 L 117 139 
Total 124 147  
 
After stratification by year, the observed association disappears. 
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Figure A-4.7a and A-4.7b. Stratification of HIP administration among cases and non-
cases by year for cohort study of R. equi pneumonia in foals 
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